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FOREWORD
This dissertation is divided into four chapters. The 
first chapter is a general introduction that presents 
background material on the functioning of mitochondria and 
techniques used in mitochondrial research. It also 
describes the physiological significance of the peroxidic 
compounds studied in the following chapters.
Chapter two is a manuscript entitled "Benzoyl Peroxide 
Interaction With Mitochondria: Inhibition of Respiration 
and Induction of Rapid, Large-Amplitude Swelling." This 
paper has been submitted for publication to Archives of 
Biochemistry and Biophysics. This work was presented as a 
poster at the 194th National Meeting of the American 
Chemical Society in September 1987. An abstract of this 
presentation was published in Biochemistry, Vol. 26, p.
4169 (1987). It will also be presented as a poster at the 
Gordon Conference on Oxygen Radicals in February 1989 by 
Dr. Pryor.
Chapter three is a communication entitled 
"Hydroperoxide-Induced Radical Production in Liver 
Mitochondria" that was published in Biochemical and 
Biophysical Research Communications, Vol. 141, pp. 1123- 
1129.
Chapter four is a manuscript also entitled 
"Hydroperoxide-Induced Radical Production in Liver 
Mitochondria." This paper is a continuation of the work
iii
described in chapter three. It is currently in preparation 
and will be submitted to Archives of Biochemistry and 
Biophysics in the near future. It will also be presented 
as a poster at the Gordon Conference on Oxygen Radicals in 
February 1989 by Dr. Church.
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ABSTRACT
When micromolar concentrations of benzoyl peroxide 
(BPO) are added to rat liver mitochondria, inhibition of 
mitochondrial NADH-oxidase and succinoxidase is observed. 
The addition of a classical uncoupler of oxidative 
phosphorylation results in only partial release of this 
inhibition, suggesting that BPO inhibits both electron- and 
energy-transfer in mitochondria. Difference spectroscopy 
and artificial electron donor results indicate that BPO 
interacts at coupling site II between cytochromes b and ci* 
BPO only yields radicals in mitochondria via inhibition of 
electron transport, which results in the formation of 
superoxide radicals. BPO also induces rapid, large- 
amplitude swelling of mitochondria; the swelling is 
dependent on the presence of monovalent cations but is 
independent of the presence of calcium, oxygen and 
respiratory substrate. BPO-induced swelling appears to be 
disassociated from radical production and lipid 
peroxidation.
When isolated rat liver mitochondria are treated with 
millimolar concentrations of tert-butyl hydroperoxide 
(TBHP), methyl, tert-butoxvl and tert-butylperoxyl radicals 
are detected using the ESR spin-trapping technique. The 
addition of respiratory substrate results in a significant 
increase in methyl radical production, no change in the 
concentration of tert-butoxyl radicals, and complete loss
xvii
of tert-butylperoxyl radicals. One-electron reduction of 
TBHP by the electron transport chain results in the 
formation of tert-butoxyl radicals, which subsequently 
undergo beta-scission to form methyl radicals. The site of 
interception of electrons by TBHP is shown to be cytochrome 
C1 fc>Y the use of classical chain inhibitors and depletion 
of mitochondrial cytochrome c. TBHP also appears to 
interact with a tightly-liganded metal in non-respiring 
mitochondria, as metal chelators have no effect on TBHP- 
induced radical production while sodium cyanide inhibits 
this process. TBHP induces lipid peroxidation in both 
respiring- and non-respiring mitochondria, as measured by 
the thiobarbituric acid test, although the degree of 
peroxidation is less in respiring mitochondria. Radical 
production is also observed when either cumene 
hydroperoxide or linoleic acid hydroperoxide is added to 
mitochondria in the presence of spin trap. The mechanisms 
of TBHP-induced radical production in both respiring- and 
non-respiring mitochondria are discussed.
xviii
CHAPTER ONE
INTRODUCTION TO MITOCHONDRIAL RESEARCH
Morphology of Mitochondria. The average mitochondrion 
is an oval particle, 1 - 2 M m  long and 0.5 - 1 M m  wide; 
these dimensions are approximately the same in all sources 
of this organelle (1).
Mitochondria are composed of two different membranes 
(Pig. 1). The outer membrane is a continuous bag that 
encloses the entire contents of the mitochondrion. The 
inner membrane has a larger surface area than the outer 
membrane, resulting in a series of folds that project into 
the interior space; these folds are referred to as 
mitochondrial cristae (2).
Two internal compartments are found in the 
mitochondrion (Fig. 1). The intermembrane (or
intracristal) space is located between the outer and inner
membranes, and the matrix (or intercristal space) is 
enclosed by the inner membrane (2). The relative areas of 
these two spaces are dependent on the conformation of the 
mitochondria. The conformation is, in turn, contingent on 
the physiological state of the mitochondria (3). During a
state of low energy (state 4 respiration, ADP is the
limiting factor), the mitochondrion assumes an orthodox 
conformation in which the cristae are folded into sheets 
and the matrix occupies most of the internal space (Fig.
2INNER
MEMBRANE
OUTER
MEMBRANE
INTERMEMBRANE
S P A C E
MATRIX
Figure 1; Morphology of the mitochondrion.
ORTHODOX CONDENSED
CONFORMATION CONFORMATION
Figure 2: Energy-linked conformational changes in the mitochondrion.
2). In a state of high energy (state 3 respiration, rate 
of electron transfer is the limiting factor), the spatial 
arrangement of the inner membrane changes to a condensed 
conformation in which the intermembrane space increases 
because of a separation of the cristae surfaces; this 
results in a decrease in the volume of the matrix (Fig. 2). 
These energy-linked changes in conformation provide a 
rationale for the observation of low-amplitude 
mitochondrial swelling when this organelle undergoes a 
change from state 3 to state 4 respiration (4). Since 
energy-linked structural changes are reversible (3), low- 
amplitude swelling is also a reversible process.
Unlike low-amplitude swelling, large-amplitude 
mitochondrial swelling is not necessarily related to the 
energy state of the mitochondrion. Exposure of 
mitochondria to either an isotonic medium containing 
permeable cations and anions or a hypotonic medium results 
in large-amplitude swelling while subsequent exposure to 
hypertonic medium causes contraction (5,6) (Fig. 3). 
Swelling results in the distention and usually the 
disruption of the outer mitochondrial membrane (7) (Fig.
3). The inner membrane unfolds during swelling but, in 
most cases, remains intact. During contraction, the inner 
membrane refolds while the outer membrane becomes detached 
from the inner membrane (7). In some cases, outer membrane 
fragments remain attached to the inner membrane (7).
|  Swell ing Agent
Early S t a g e  
of Swelling
L a t e  S ta g e V  
of Swel l ing  )
A T P
Contraction  
of  Inner  
Membrane
m
Figure 3: Conformational changes in the mitochondrion during large - 
amplitude swelling and contraction.
Although the changes caused by swelling to the inner 
membrane can be reversed, the outer mitochondrial membrane 
is destroyed. Thus, large-amplitude swelling in which the 
outer membrane is disrupted is an irreversible process.
Oxidative Phosphorylation. The most important 
function of mitochondria is to convert energy obtained from 
the oxidation of substrates into energy stored in the form 
of a phosphate bond in adenosine triphosphate (ATP) which 
may be utilized upon hydrolysis. Normal mitochondrial 
functioning is therefore dependent on the coupling of 
oxidation and phosphorylation.
The free energy of oxidation necessary to drive the 
process of oxidative phosphorylation is derived principally 
from oxidation of fatty acids (beta-oxidation) (8) and 
citric acid cycle intermediates (9). The energy obtained 
from oxidation is stored as reducing potential in the form 
of nicotinamide adenine dinucleotide (NADH) and flavin 
adenine dinucleotide (FADH2 )• These reducing equivalents 
are then used to drive mitochondrial electron transport.
The electron transport chain (ETC) is located in the 
inner mitochondrial membrane (10). NADH and FADH2 are 
utilized at different sites on the ETC (Fig. 4). NADH, 
produced by oxidases distinct from the ETC, transfers 
electrons to the chain at NADH-oxidase (or NADH 
dehydrogenase), which is called complex 1 (11). FADH2 1 on 
the other hand, is produced directly on the ETC through
NAD-Linked
Substrates — > n a d
{e.g.£-OH Butyrate)
Succinate
Coupling Site I
2H+
I----
NADH Oxidase 
(Complex 1 )
FP ,(4Fe*S)
FP2 (Fe • S)
Succinoxidase 
(Complex 2)
Coupling Site I
2 H +
Coupling Site IE 
+
 1
QH£-Cytochrome C
R eductase
(Complex 3)
r
2 H  
1
Cytochrome C 
Oxidase 
(Complex 4)
cytb(Fe*S)cytct
t
Inhibited by 
Antimycin A
> cy tc .-
t
TMPD
cytao, -^ •0,
t
Inhibited by 
Cyanide
Figure 4: The mitochondrial electron transport chain.
oxidation of succinate by succinoxidase (or succinate 
dehydrogenase), which is called complex 2 (12). Both of 
these complexes transfer electrons to coenzyme Q 
(ubiquinone) (13) which is the first of two mobile carriers 
on the ETC that act as shuttles between respiratory 
complexes (1). According to the classical description of 
the ETC, electrons are then transferred in a linear fashion 
through coenzyme Q-cytochrome c reductase (complex 3) to 
cytochrome c (14,) which is the second mobile carrier on 
the ETC (1). Finally, electrons are transferred from 
cytochrome c to cytochrome oxidase (complex 4) which 
reduces oxygen, the terminal electron acceptor, to water 
(15) .
A significant amount of evidence has been presented 
that contradicts the linear flow of electrons through 
complex 3 depicted in figure 4 (16-18). An alternative 
model, termed the protonmotive Q cycle (19) (Fig. 5), has 
been proposed to account for the observed discrepancies 
from the classical theory of linear electron transport. In 
this scheme, ubiquinol (QH2 , reduced form of coenzyme Q) is 
oxidized to a semiquinone (QT , radical form of coenzyme Q) 
via transfer of one electron to an iron-sulfur protein 
which then reduces cytochrome ci. The semiquinone is then 
oxidized to ubiquinone (Q, oxidized form of coenzyme Q) by 
transfer of one electron to cytochrome b-566, which then 
reduces cytochrome b-562. These reactions are believed to
NADH OXIDASE 
OR
SUCCINOXIDASE
H
ANTIMYCIN
CYT B - 5 6 2
CYT B - 5 6 6
QH
2H (F E -S )
Figure 5: The protonmotive Q cycle.
ELECTRONEGATIVE
SIDE
ELECTROPOSITIVE
SIDE
occur on the electropositive side of the inner membrane. 
Ubiquinone, on the electronegative side of the inner 
membrane, is then reduced to a semiquinone by cytochrome b- 
562. Either NADH-oxidase or succinoxidase then reduces the 
semiquinone to ubiquinol to continue the cycle. Thus, 
.according to the Q-cycle model, there are two separate 
binding domains for ubiquinone, located on opposite sides 
of the inner membrane. Another model, termed the SQ-cycle 
(20), suggests that there is only one binding domain for 
ubiquinone, and the semiquinone radical of coenzyme Q acts 
as both an oxidant and reductant of cytochrome b. Recent 
kinetic evidence has provided support for the original Q- 
cycle hypothesis (21). Thus, electron flow through complex 
3 is not linear and is believed to occur via the scheme 
shown in Fig. 5. The most important aspect of the Q-cycle 
model is that it explains how two protons are pumped per 
electron transferred through coenzyme Q-cytochrome c 
reductase.
The chemiosmotic theory proposes that electron 
transport and the production of ATP from adenosine 
diphosphate (ADP) and inorganic phosphate are coupled 
through an electrochemical gradient across the inner 
mitochondrial membrane (22) . As electrons flow down the 
ETC, there are three sites at which the change in redox 
potential is sufficiently large to obtain enough energy to 
pump two protons from the electronegative side of the inner
11
membrane (matrix) to the electropositive side 
(intermembrane space). These sites, termed coupling sites 
I, II and III, are found in complexes 1, 3 and 4 (Fig. 4). 
Thus, energy is expended to pump protons against an 
electrochemical gradient. The production of ATP is then 
driven by a flow of protons from the intermembrane space 
through H+-ATPase to the matrix.
The rate of respiration has been proposed to be a 
function of the overall thermodynamic driving force on the 
electron transport chain, 2AEj1-nAP, where AE^ is the 
difference in redox potential across the E T C , A p  is the 
protonmotive force and n is the H+/0 stoichiometry of the 
ETC (23). Thus, a decrease in A p  will result in an 
increase in respiration rate. Both classical uncouplers 
(which imbed themselves in the inner membrane and shuttle 
protons from the intermembrane space to the matrix) and ADP 
(which also allows protons to flow across the membrane 
because it is a substrate for H+-ATPase) cause a decrease 
in A p  and stimulate respiration (24,25) . This decrease in 
AP is believed to stimulate respiration via an increase in 
the rate of proton pumping; this results in an increase in 
the rate of electron transport due to the coupling of the 
ETC with proton pumping (26).
Measurement of Mitochondrial Respiration. Measurement 
of the integrity of mitochondria is based on the coupling 
between respiration and phosphorylation. Mitochondrial
respiration is normally measured polarographically using a 
Clark-type oxygen electrode (27). Two different 
measurements are used to quantitate the integrity of 
mitochondrial preparations. The respiratory control ratio 
(RCR) refers to the ratio of state 3 respiration (high 
concentration of both substrate and ADP) to state 4 
respiration (high concentration of substrate, low 
concentration of ADP); the rate of state 4 respiration is 
measured after ADP has been consumed (Fig. 6) (27). In
tightly coupled mitochondria, the rate of state 4 
respiration is slow; a rapid increase in oxygen uptake is 
observed upon the addition of ADP. If no stimulation of 
respiration rate is observed after adding ADP, the RCR 
equals 1, indicating that electron transport is completely 
uncoupled from phosphorylation. In Fig. 6, the RCR of the 
preparation is 5.8. RCR values below 3 are considered to 
be indicative of a poor preparation. The duration of state 
3 respiration is dependent on the amount of ADP added to 
the mitochondrial suspension. The ADPiO ratio, another 
measurement of mitochondrial integrity, takes advantage of 
the fact that the concentration of oxygen consumed is 
proportional to the amount of ADP converted to ATP (27). 
This ratio is calculated by dividing the moles of ADP added 
by the moles of 0 (not O2 ) consumed during state 3 
respiration (see A o  in Fig. 6). In Fig. 6, the ADP.*o 
ratio of the preparation is 1.4. For every two protons
13
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Figure 6: Measurement of respiratory control ratio (RCR) and ADP:0 
ratio in respiring mitochondria. RCR - rate of oxygen uptake during 
state 3 respiration/rate of oxygen uptake during state 4 
respiration. ADP:0 ratio - nmoles ADP added/nmoles 0 used during 
state 3 respiration.
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pumped against the electrochemical gradient, one ADP should 
theoretically be converted to ATP (28) . Thus, the 
theoretical ADPiO ratio is 3 when NAD-1inked substrates are 
used since six protons are pumped per NADH utilized. The 
theoretical ADP:0 ratio is 2 when succinate is the 
substrate since only four protons are pumped per FADH2 
consumed.
Characterization of Toxins as Inhibitors of 
Mitochondrial Function. Numerous toxins have been shown to 
directly disrupt mitochondrial oxidative phosphorylation by 
inhibiting either electron transport, ATP synthesis or 
substrate/ion transport or by uncoupling respiration from 
phosphorylation (29). Mitochondria are essential for the 
normal functioning of cells and destruction of this 
organelle results in cell death (3 0). Mitochondria can be 
implicated as a major target of toxicity by demonstrating 
that a toxin is a mitochondrial inhibitor.
A toxin can be characterized as a mitochondrial 
inhibitor by examining its effect on mitochondrial 
respiration. The most commonly used technique for 
accomplishing this is the measurement of oxygen uptake. If 
a stimulation in oxygen uptake is observed when a toxin is 
added to mitochondria during state 4 respiration and the 
degree of stimulation is independent of added ADP, then the 
toxin may be classified as an uncoupler of respiration 
(31). If a decrease in oxygen uptake is observed when a
toxin is added during state 3 respiration, then the toxin 
may be an inhibitor of either the respiratory chain (32), 
ATP synthesis (33), substrate/ion transport (34,35) or a 
combination of these. A classical uncoupler such as 
carbonyl cyanide m-chlorophenylhydrazone (CCCP) may be 
added to determine if respiration can be stimulated in the 
presence of the toxin. If respiration is not stimulated, 
then the toxin is a respiratory chain inhibitor. If 
inhibition of respiration is completely reversed by CCCP, 
then the toxin is an inhibitor of ATP synthesis. It is 
possible to distinguish between an inhibitor of ATP 
synthesis and an inhibitor of substrate/ion transport by 
measuring ATPase activity in submitochondrial particles in 
the presence of the toxin. ATPase activity is affected by 
inhibitors of ATP synthesis whereas it is unaffected by 
inhibitors of substrate/ion transport. These latter 
inhibitors are also characterized by the fact that they do 
not completely inhibit oxygen consumption and ATP synthesis 
in whole mitochondria (36).
If a toxin is characterized as a respiratory chain 
inhibitor, the site of interaction on the ETC may be probed 
by adding the toxin during both NAD- and FAD-1inked 
respiration. If NAD-linked respiration is inhibited but 
FAD-1inked respiration is not, then the site of interaction 
is complex 1. If the converse is true, then the site of 
interaction is complex 2. Inhibition of both types of
respiration suggests that the toxin interacts with a site 
downstream on the respiratory chain. N/N/N'/N'- 
tetramethyl-p-phenylenediamine (TMPD) is an artificial 
electron donor that transfers electrons to cytochrome c 
(Fig. 4) (37). If release of inhibition of respiration is
observed in the presence of TMPD, then the toxin interacts 
at complex 3. If no stimulation of oxygen uptake is 
observed with TMPD, then the toxin inhibits complex 4.
Difference spectroscopy is a technique that employs 
measurement of the spectral properties of chain components 
in the visible region (400 - 7 00 nm) to determine the site 
of interaction of a toxin with the respiratory chain (38). 
The absorbance of respiring mitochondria (or respiring 
submitochondrial particles) treated with the toxin is 
compared to untreated, oxidized mitochondria (or 
submitochondrial particles). If a toxin interacts 
specifically with either complex 1 or complex 2, no 
accumulation of reduced cytochromes will be observed. If a 
toxin interacts with complex 3 in a manner analogous to 
antimycin A, an inhibitor of proton pumping site II, then 
an accumulation of only cytochromes b will be observed 
(Fig. 7A). If a toxin interacts with complex 4, then 
cytochromes b, c and a will all accumulate in their reduced 
form (Fig. 7B). Thus, difference spectroscopy is a useful 
probe of toxin-ETC interactions.
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Figure 7: Accumulation of reduced cytochromes in respiring SMP 
blocked at complex 3 (A) and complex 4 (B). (A) Accumulation of
cytochrome b resulting from the treatment of respiring SMP with 
antimycin A. (B) Accumulation of cytochromes a, b and c resulting 
from the treatment of respiring SMP with sodium cyanide. Greek 
symbols refer to the individual absorption bands of the cytochromes.
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Electron spin resonance spectroscopy (ESR) , a 
technique used to detect paramagnetic species, can also be 
used to probe the site of interaction of toxins with the 
respiratory chain because a buildup of reduced coenzyme Q 
results in a one-electron reduction of O2 to 0 2 T 
(superoxide radical) via the semiquinone radical of 
coenzyme Q (39). Direct detection of radicals by ESR 
depends on the buildup of a steady-state concentration of 
these species. Due to their reactivity, many radicals have 
a short lifetime. Thus, it is sometimes difficult to 
obtain a sufficient concentration of radicals in biological 
systems to allow for direct detection by ESR. This problem 
has been solved by the introduction of spin traps (40-45). 
The most common spin traps are nitrones. Two of the most 
popular nitrones for ESR spin-trapping experiments are 5,5- 
dimethyl-l-pyrroline-N-oxide (DMPO) and alnha-phenyl N- 
tert-butyl nitrone (PBN).
1 H = N  C(CH;t);
Os
DMPO PBN
Nitrones react with short-lived free radicals to produce 
nitroxide (or aminoxyl) radicals which are termed "stable" 
radicals (46) (Equation 1).
0“  0*
I I
RX-CH-N-R2 + r3 --- > Ri-CH-N-R2 (1)
+ I
r3
The stability of nitroxides is due to resonance 
stabilization of the unpaired electron in the monomer and 
the fact that strong bonds cannot be formed in the dimer 
(46) .
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The actual stability of the nitroxide is dependent on the 
free radical that is trapped.
In an electromagnetic field, there is a certain 
frequency (termed the resonance frequency) at which a free 
electron will absorb an amount of energy equal to the 
energy-level separation between its two possible spin
states (47). In an ESR spectrum, which is normally 
recorded as the first derivative spectrum, this absorption 
results in a single line (Fig. 8A). The interaction of an 
unpaired electron with a nuclear species possessing nuclear 
spin (e.g., I = 1/2, 1, 3/2, etc.) results in a splitting 
of the single line into multiple lines of equal intensity. 
The number of lines observed from the interaction of an 
unpaired electron with a single nucleus is equal to 21 + 1. 
For example, hydrogen (I = 1/2) splits the single line into 
two lines (Fig. 8B) while interaction with nitrogen ( 1 = 1 )  
results in three lines (Fig. 8C). The quantity hA0 , where 
h is Plank’s constant and A0 is the isotropic hyperfine 
coupling constant, is a measure of the interaction energy 
between the electron and the nucleus. In an ESR spectrum, 
the separation between lines due to interaction of an 
unpaired electron with a single nucleus is defined as the 
hyperfine splitting constant (a). The hyperfine splitting 
and coupling constants are related by the equation a = 
hA0/g>B , where h is Plank's constant, g is the g factor,
i
and J5 is the Bohr magneton (47) . These constants are 
useful for the identification of radicals since most ESR 
spectra arise via coupling of electron and nuclear spin.
In the case of both DMPO- and PBN-radical adducts, 
splittings are observed due to the interaction of the 
unpaired electron with the both the nitrogen and beta- 
hydrogen on the trap. If these splittings are
21
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Figure 8: Effect of nuclear spin on the splitting of the ESR signal 
of an unpaired electron. (A) ESR signal of an unpaired electron.
(B) Effect of a single hydrogen nucleus on A where ajj => 1.5 mT.
(C) Effect of a single nitrogen nucleus on A where ajj -* 1.5 mT. 
Sweep .width - 9.0 mT.
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significantly different, the result is a six-line ESR 
signal (Fig- 9). The interaction energy between the 
unpaired electron and beta-hydrogen nucleus is greater in a 
DMPO adduct (Fig. 9A) than it is in a PBN adduct (Fig. 9B), 
resulting in larger hydrogen splittings. Thus, the ESR 
spectrum of a DMPO adduct provides more information about 
the trapped species than does a PBN adduct.
The ESR spin-trapping technique can be used in a 
respiring mitochondrial system to determine whether a chain 
inhibitor blocks electron flow on the oxidase side of 
coenzyme Q. For example, when respiring beef heart 
mitochondria are treated with antimycin A, an inhibitor of 
complex III (Fig. 4), in the presence of DMPO, the 
formation of a superoxide-DMPO adduct is observed (48).
This technique can also provide direct evidence for the 
interaction of a toxin with mitochondria via a radical 
pathway. For example, tert-butyl hydroperoxide (TBHP) has 
been shown to damage mitochondria by a non-radical pathway 
involving calcium cycling (49-51). We have used the ESR 
spin-trapping technique to show that TBHP also interacts 
with mitochondria by a radical pathway (52). Thus, ESR 
shows great promise for the study of toxin/mitochondrial 
interactions.
In addition to disturbing mitochondrial oxidative 
phosphorylation, certain toxins also induce changes in the 
morphology of mitochondria (29). These changes can be
o
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Figure 9: Gaussian Simulations of ESR snectra nf mon,„i j- , 
adduces of DMPO and PBN. (A, M e t h y l D ^ d d ^ t  s £ £  ge™ra\\d 
using hfsc of a„ - 1.43 mT and a„ - 2.05. (B) Methyl-Psfadduct
: ds"h1. T o er: r d u s l n 6  h f s c  ° f *n  - 1-« bi
measured by following the decrease in turbidity of a 
mitochondrial suspension using a visible spectrophotometer. 
This physical phenomenon is referred to as mitochondrial 
swelling. As stated previously, a change in the energy 
state of the mitochondrion from high to low energy results 
in a conversion from a condensed to an orthodox 
conformation (3). This conformation change is the basis of 
reversible low-amplitude, energy-linked mitochondrial 
swelling (4). A change from condensed to orthodox 
conformation also occurs during large-amplitude swelling, 
but this type of swelling is not necessarily related to the 
metabolic state of the mitochondrion. Lysis of the outer 
mitochondrial membrane also occurs in most cases of large- 
amplitude swelling making this process irreversible (7). 
Toxin-induced mitochondrial swelling has been shown to 
occur by a number of different mechanisms. For example, 
calcium cycling (49-51), lipid peroxidation (53), and 
oxidation of sulfhydryl groups (54) have all been 
implicated in this process. Mitochondrial swelling is an 
important indicator of the toxicity of a compound since 
this change of morphology and loss of mitochondrial 
membrane potential have been shown to precede cell death 
(30) .
By using the techniques described above, it is 
possible to determine if a compound is a mitochondrial 
toxin and, if so, to probe the mechanism of toxicity.
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PHYSIOLOGICAL SIGNIFICANCE OF BENZOYL PEROXIDE
Preparation and Uses of Benzovl Peroxide. Benzoyl 
peroxide (BPO) is a free radical-generating compound that 
is commonly used in the chemical industry as an initiator 
of radical processes and in the pharmaceutical industry as 
an active ingredient in many acne medicines. BPO is 
prepared by treatment of benzoyl chloride with either 
hydrogen peroxide in alkaline medium (55) or sodium 
peroxide in acetone (56).
Effect of BPO on Skin. Since BPO is used in acne 
medicines, its effect on skin is of interest. When used 
undiluted or at high concentrations, BPO is a potent skin 
irritant (57) and causes epidermal hyperplasia (58). These 
findings prompted further study into the action of BPO on 
skin with emphasis on its ability to participate in 
carcinogenesis.
Three Stage Model of Skin Carcinogenesis. Skin 
carcinogenesis can be divided into initiation, promotion 
and progression stages. Tumor initiation is an 
irreversible step that arises from the interaction of a 
carcinogen with DNA resulting in gene alteration (59). 
During the promotion stage, the altered genetic material of 
the initiated cell becomes expressed through selection and 
clonal expansion (60). This process is facilitated by the 
ability of the tumor promoter to both increase the rate of 
terminal differentiation of the non-initiated cells and
exhibit toxic effects on these cells (61). The result of 
initiation followed by promotion is commonly the formation 
of a high yield of benign tumors. The progression of 
tumors from a benign to malignant neoplasm occurs in the 
final stage of carcinogenesis; this transformation is 
proposed to involve further genetic changes caused by 
mutagenic agents (62,63). This model of carcinogenesis has 
been shown to exist in a number of systems including the 
liver (64).
Activity of Peroxidic Compounds in Tumor Promotion. 
Although BPO is inactive as a tumor initiator or complete 
carcinogen (65), it is both an effective skin tumor 
promoter (66) and enhancer of progression (67). Several 
other peroxidic compounds are also active as tumor 
promoters; cumene hydroperoxide (CHP), decanoyl peroxide, 
dicumyl peroxide, and lauroyl peroxide are strong promoters 
while tert-butyl hydroperoxide (TBHP), hydrogen peroxide, 
and methyl ethyl ketone peroxide are less active (58,68- 
70). It has been suggested (58) that detoxification of 
H 2O2 and organic hydroperoxides by cellular catalase and 
glutathione peroxidase (71) may prevent some of the 
intracellular effects of these compounds resulting in a 
lowered tumor promoting activity. Organic peroxides, 
unlike hydroperoxides, are not metabolized by glutathione 
peroxidase (72) ; therefore, the effective cellular 
concentration of the peroxides may be higher than the
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hydroperoxides, resulting in a higher tumor promoting 
activity. Although this theory is reasonable, it does not 
explain the fact that cumene hydroperoxide is a good tumor 
promoter.
Induction of Morphological and Biochemical Changes in 
Skin bv BPO. Tumor promoters have been found to cause a 
number of morphological and biochemical changes in skin 
(73). Of these effects, the induction of epidermal cell 
proliferation, dark basal keratinocyte production, and 
ornithine decarboxylase activity show the best correlation 
with tumor promoting activity (74-79).
Keratinocytes are electron-dense, ribosome-rich basal 
cells which are observed during inflammation and epidermal 
hyperplasia (77-79). BPO is an effective hyperplasiogenic 
agent when applied to rodent skin and results in a 
sustained production of keratinocytes (58). BPO inhibits 
metabolic co-operation in cultured human keratinocytes (80) 
and has been shown to produce single strand breaks in 
cultured human bronchial epithelial cells (81), mouse 
keratinocytes (82) and keratinocyte-derived cell lines 
(83). The latter effect may be important in the role of 
BPO as an enhancer of tumor progression (67) since this 
stage of carcinogenesis is believed to involve genetic 
changes (62,63).
A recent study has shown that mouse keratinocytes 
derived from initiated skin or papillomas are resistant to
DNA strand breakage by BPO and suggests that this may be 
important with regard to BPO-mediated tumor promotion (84). 
As stated previously, expression of initiated cells is 
facilitated by the ability of the tumor promoter to both 
increase the rate of terminal differentiation of the non­
initiated cells and exhibit toxic effects on these cells 
(61). The induction of single strand breaks in non­
initiated keratinocytes by 12-O-tetradecanoyl phorbal-13- 
acetate (TPA), a strong tumor promoter, has been related to 
its ability to induce terminal differentiation (82). 
Induction of terminal differentiation is proposed to occur 
via activation of protein kinase C (85). Although BPO has 
been shown to activate protein kinase C in epidermal cell 
membranes (86) and induce single strand breaks in normal 
basal keratinocytes (non-initiated), it does not induce 
terminal differentiation in these cells (82). Thus, 
resistance to differentiation may provide initiated cells 
with a selective advantage in phorbal ester-mediated tumor 
promotion while resistance to cytotoxicity may provide this 
advantage in BPO-mediated tumor promotion (82).
Involvement of Free Radicals in Tumor Promotion and 
Peroxide-Induced Cytotoxicity. Free radicals have been 
implicated in the tumor promotion stage of carcinogenesis 
(87,88). As stated previously, one of the roles of a tumor 
promoter is to exhibit toxic effects on uninitiated cells 
(61). The ability of BPO to induce lipid peroxidation in
human epidermal keratinocytes has been probed to determine 
whether this radical process is related to cell damage 
caused by BPO (89). BPO does not induce lipid peroxidation 
in these cells (89) ; therefore, the cytotoxicity of BPO 
must be attributed to a process distinct from lipid 
peroxidation. Possibilities include oxidation of proteins 
(90), production of strand breaks in DNA (81-83), or the 
inhibition of mitochondrial respiration (91).
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PHYSIOLOGICAL SIGNIFICANCE OF HYDROPEROXIDES
Formation of Hydroperoxides. Although cyclic 
peroxides are still believed to be formed in the 
peroxidation of polyunsaturated fatty acids (PUFA) (92,93), 
the primary reaction products of autoxidation are 
hydroperoxides. The mechanism for the autoxidation of PUFA 
commonly accepted today was first proposed by Bolland and 
Koch in 1945 (94) (Equations 2-4).
R-CH-CH=CH-CH=CH-R
-H*
R-CH“CH-CH2-CH=CH-R ------------- R-CH*=CH-CH“CH=CH-R (2)
i
R - CH-CH-CH=CH-CH-R
R-CH=CH-CH-CH=CH-R + O2  *-> R-CH=CH-CH-CH=CH-R (3)
I
00 *
R -CH“CH-CH-CH=CH-R + RH ----=>- R-CH=CH-CH-CH=CH-R + R- (4)
I I
00■ 00H
Equation 2 represents the initiation step in which a 
reactive species abstracts a hydrogen atom from an alpha- 
methylene group of a PUFA. In biologically relevant PUFA, 
these methylene groups are doubly allylic due to the
position of the double bonds (e.g. linoleic acid is a 9,12 
unsaturated fatty acid); the doubly allylic hydrogens in 
these compounds are more labile than the alpha-methvlene 
hydrogens found in mono-unsaturated compounds (e.g. oleic 
acid) and are therefore more susceptible to abstraction.
For this reason, PUFA are more easily oxidized than are 
either saturated or mono-unsaturated fatty acids. The 
radical formed by abstraction of a hydrogen atom (Equation 
2) can isomerize to form three resonance hybrid free 
radicals. Each of these carbon-centered radicals can then 
react readily with oxygen to form a peroxyl radical 
(Equation 3). The peroxyl radical then abstracts a 
hydrogen atom from another PUFA molecule to form a 
hydroperoxide and a new carbon-centered radical that is 
capable of continuing this chain reaction (Equation 4). 
Equations 3 and 4 are the propagation steps in 
autoxidation. Termination of the chain results when either 
two radicals react to form non-radical products or when a 
radical abstracts a hydrogen atom from a compound that 
yields a less-reactive radical.
The occurrence of autoxidation (or lipid peroxidation) 
in a biological system was first observed by incubating 
homogenates of liver, kidney, and brain under aerobic 
conditions and estimating the extent of peroxidation by the 
thiobarbituric acid (TBA) test (95,96).
Decomposition of Hydroperoxides. The bond 
dissociation energy (BDE) of the oxygen-oxygen bond in 
simple alkyl hydroperoxides is fairly strong. For example, 
the BDE of tert-butyl hydroperoxide (TBHP) is 43 kcal/mole 
(97). Thus, the rate constant for the uncatalyzed, 
unimolecular decomposition of TBHP (Equation 5) at 37°C is
t-BuOOH --------> t-BuO- + HO* (5)
5 X 10”16 sec”1, and the half life for TBHP at 37°C is 
about lo9 years (98). Since the BDE of the oxygen-oxygen 
bond should be similar for all simple alkyl hydroperoxides 
(99,100), uncatalyzed thermal decomposition is not likely 
to be an important route for breakdown of these compounds 
under physiological conditions (101).
Transition metal complexes readily catalyze the 
decomposition of hydroperoxides in vitro via Fenton 
reactions (102-104) to yield alkoxyl and peroxyl radicals 
(Equations 6 and 7).
Fe2+ + R00H --------> Fe3+ + R0» + HO' (6)
Fe3+ + ROOH -------- > Fe2+ + R00* + H+ (7)
Decomposition of hydroperoxides via metal-catalyzed redox 
reactions is expected to be an important process in 
biological systems since hydroperoxides are degraded by 
metals from endogenous sources such as heme proteins (105- 
107). Iron released from ferritin and hemosiderin
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initiates lipid peroxidation (108-110), so these iron 
sources may also be involved in radical generation by 
hydroperoxides in vivo.
Three different mechanisms have been proposed to 
account for the radicals observed when heme proteins are 
treated with hydroperoxides. Heme proteins are believed to 
catalyze the decomposition of hydroperoxides via Fenton 
reactions (Equations 6 and 7) (111,112). An alternative
mechanism has been proposed in which the initial event is 
homolytic cleavage of the oxygen-oxygen bond of the 
hydroperoxide molecule by the heme (113) (Equations 8 and 
9); this reaction results in the formation of an alkoxyl 
radical and heme-bound hydroxyl radical.
porphyrin-Fe*** + R00H --- > porphyrin-Fe^-OH + RO* (8)
porphyrin-Fe^-OH + ROOH --- > porphyrin-Fe1-*1 + R O O  + HjO (9)
The products of both of these mechanisms is an alkoxyl 
radical, a peroxyl radical and water. Several heme 
proteins are also believed to catalyze the decomposition of 
hydroperoxides via a peroxidase-type mechanism resulting in 
the formation of peroxyl radicals (114-117) (Equations 10 
and 11).
porphyrin-Fe-^* + R O O H  > porphyrin-Fe^=0 + ROH (10)
+•
porphyrin-Fe*V“0 + ROOH ----> porphyrin-Fe*v=0 + ROO* + H+ (11)
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Radicals produced via the decomposition of lipid 
hydroperoxides by endogenous iron may cause cellular damage 
through interaction with DNA (118,119), proteins (120,121) 
or lipids (to yield further lipid peroxidation) (122,123).
Involvement of Hydroperoxides in Carcinogenesis.
Organic hydroperoxides have been shown to have varying 
degrees of tumor promoting activity in the initiation- 
promotion model of mouse epidermis; cumene hydroperoxide 
(CHP) is a strong promoter, TBHP and methyl ethyl ketone 
peroxide are weak promoters, and hydrogen peroxide is a 
very weak promoter (58,68-70).
The ability of hydroperoxides to induce radical 
production in mouse keratinocytes, a target cell for tumor 
promoters, has been measured by the ESR spin-trapping 
method; both CHP and TBHP are effective radical generators 
in these cells (124). Surprisingly, TBHP does not induce 
lipid peroxidation in keratinocytes (89). Therefore, 
radicals generated by TBHP must be either readily scavenged 
in these cells or participate in another type of cellular 
damage such as modification of proteins or DNA. Lipid 
peroxidation is not a requisite for TBHP-induced cell death 
in hepatocytes (125) indicating that other types of damage 
must be involved in the toxicity of this compound. Kensler 
and Taffe have suggested that methyl radicals produced in 
hydroperoxide-treated keratinocytes may modulate the cell 
phenotype during promotion or progression by alkylating
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cellular macromolecules (87). This is a reasonable 
hypothesis since methylation reactions are believed to be 
involved in eukaryotic gene expression (126) .
The fact that TBHP, unlike BPO, does not reduce the 
cell viability of normal mouse keratinocytes (89) may 
provide a rationale for the difference in skin tumor- 
promoting activity of these two peroxidic compounds. Since 
tumor cells are resistant to lipid peroxidation (127,128) 
and neither BPO nor TBHP initiate this radical process in 
normal cells (89), it can be proposed that lipid 
peroxidation is not an important process in peroxide- 
mediated tumor promotion in skin.
Possible Involvement of Mitochondria in Carcinogenesis 
and Mechanisms of Interaction of Hydroperoxides With These 
Organelles. Many carcinogens are known to interact 
preferentially with mitochondrial DNA, suggesting that the 
mitochondrion may be a target organelle for these compounds
(129). Chemical carcinogens might transform cells by 
interacting at the locus of the mitochondrial membrane 
resulting in loss of genetic material through the membrane 
into the cell where it acts as an exogenous oncogenic virus
(130).
Mitochondrial function is reported to be impaired in 
cancer cells (131); these impairments include changes in 
ultrastructure, defective energy-linked functions, and 
altered Ca2+ transport. Organic peroxides have been shown
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to cause similar deviations in mitochondrial function. 
Peroxide-induced damage occurs by both radical and non­
radical pathways; for example, TBHP has been shown to 
initiate mitochondrial swelling via a non-radical process 
that is dependent on Ca2+ cycling (49-51), but TBHP also 
forms free radicals in mitochondria as shown by ESR spin 
trapping (52). Cumene hydroperoxide can also be presumed 
to yield radicals in mitochondria since it is known to 
initiate mitochondrial lipid peroxidation (132).
TBHP and CHP have been shown to induce radical 
production in keratinocytes via interaction with a 
cytosolic species (124); no radical generating activity is 
observed with the mitochondrial fraction from these cells 
(124). Thus, peroxide-mitochondrial interactions may not 
be important in skin tumor promotion if the tumor-promoting 
ability of peroxides is, in fact, directly related to their 
ability to induce radical production. The three stage 
model of carcinogenesis (initiation, promotion and 
progression) has been shown to exist in a number of systems 
including the liver (64). In liver, peroxide-mitochondrial 
interactions may be important in peroxide mediated tumor- 
promotion since hydroperoxides induce radical production in 
this organelle.
Since the mechanism of action of peroxide tumor 
promotors is controversial, it is not known whether
mitochondrial damage is important in the peroxide-mediated 
promotion stage of carcinogenesis.
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ABSTRACT
When micromolar concentrations of benzoyl peroxide 
(BPO) are added to rat liver mitochondria, inhibition of 
mitochondrial NADH-oxidase and succinoxidase is observed. 
The addition of 2,4-dinitrophenol, an uncoupler of 
oxidative phosphorylation, results in only partial release 
of this inhibition, suggesting that BPO inhibits both 
electron- and energy-transfer in mitochondria. Release of 
inhibition is also observed when an electron donor,
N,N,N',N'-tetramethyl-p-phenylenediamine, is added, 
suggesting that inhibition occurs on the substrate side of 
ferricytochrome c. When BPO is added to respiring 
submitochondrial particles (SMP), only reduced cytochrome b 
is observed to accumulate in the difference spectrum 
(reduced minus oxidized) in a manner analogous to that 
observed in the presence of antimycin A. These results 
indicate that BPO interacts at coupling site II between 
cytochromes b and c ^  When respiring SMP are treated with 
BPO in the presence of the spin trap 5,5-dimethyl-l- 
pyrroline-N-oxide, electron spin resonance signals 
attributable to the hydroxyl and superoxide adducts are 
observed. Catalase and superoxide dismutase inhibit the 
formation of these adducts, suggesting the involvement of 
both hydrogen peroxide and superoxide radicals in this 
process. BPO also induces rapid, large-amplitude swelling 
of mitochondria; the swelling is dependent on the presence
of monovalent cations but is independent of the presence 
calcium, oxygen and respiratory substrate- BPO-induced 
swelling appears to be disassociated from radical 
production and lipid peroxidation.
ABBREVIATIONS
ADP, adenosine-5 *-diphosphate; a-T, alpha-tocopherol; BHB, 
beta-hvdroxy butyrate; BPO, benzoyl peroxide; BSA, bovine 
serum albumin; CCCP, carbonyl cyanide m- 
chlorophenylhydrazone; DMPO, 5,5-dimethyl-1-pyrroline-N- 
oxide; DMPO-OH, hydroxyl adduct of DMPO; DMPO-OOH, 
superoxide adduct of DMPO; DMVN, 2,21-azo-bis(2,4- 
dimethylvaleronitrile); DNP, 2,4-dinitrophenol; DTNB, 5,5' 
dithiobis(2-nitrobenzoic acid); DTT, dithiothreitol; EDTA, 
ethylenediamine tetraacetic acid; EGTA, [ethylenebis- 
(oxyethylenenitrilo)] tetraacetic acid; ESR, electron spin 
resonance; GSH, reduced glutathione; GSSG, oxidized 
glutathione; NEM, N-ethylmaleimide; PBN, N-tert-butyl- 
alpha-phenylnitrone; PMB, p-hydroxymercuribenzoate; SOD, 
superoxide dismutase; SMP, submitochondrial particles; TBA 
2-thiobarbituric acid; TBHP, tert-butyl hydroperoxide; TCA 
trichloroacetic acid; TMPD, N,N,N',N'-tetramethyl-p- 
phenylenediamine; Tris, 2-amino-2(hydroxymethyl)-l,3- 
propanediol.
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INTRODUCTION
Several peroxidic compounds are active as tumor 
promoters; benzoyl peroxide, decanoyl peroxide, dicumyl 
peroxide, and lauroyl peroxide are strong promoters while 
tert-butvl hydroperoxide (TBHP), hydrogen peroxide, and 
methyl ethyl ketone peroxide are less active (1). Benzoyl 
peroxide (BPO) is a free radical-generating compound that 
is commonly used in the chemical industry as an initiator 
of radical processes and in the pharmaceutical industry as 
an active ingredient in many acne medicines. In addition 
to being a skin-tumor promoter (2), BPO is also an enhancer 
of tumor progression (3). At concentrations equal to or 
greater than 0.4 M, BPO is a potent skin irritant (4) and 
causes epidermal hyperplasia (5). During BPO-induced 
hyperplasia, a sustained production of dark basal 
keratinocytes is observed (5). The number of induced 
keratinocytes has been shown to correlate well with the 
tumor-promoting activity of several promoters (6,7).
Many promoters, such as the phorbal esters, are almost 
exclusively membrane-active agents. The cell membranes of 
many tissues contain high affinity, specific receptor 
proteins that interact with tumor promoters (8,9). The 
mitochondrion is a complex organelle consisting of 
membrane-bound multienzyme systems. In cancer cells, 
mitochondrial function is reported to be impaired (10); 
these impairments include changes in ultrastructure,
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defective energy-linked functions, and altered Ca2+ 
transport. Prooxidant promoters, including organic 
peroxides, have been shown to cause similar deviations in 
mitochondrial function. Although peroxidic tumor promoters 
are known to impair normal mitochondrial function, it 
remains to be established whether such impairment is 
involved in the tumor promotion process.
Free radicals have been implicated in tumor promotion 
(11,12). Peroxide-induced mitochondrial damage occurs by 
both radical and non-radical pathways; for example, TBHP 
has been shown to initiate mitochondrial swelling via a 
non-radical process that is dependent on Ca2+ cycling (13- 
15), but TBHP also forms free radicals in mitochondria as 
shown by ESR spin trapping (16). Cumene hydroperoxide also 
can be presumed to yield radicals in mitochondria since it 
is known to initiate mitochondrial lipid peroxidation (17). 
TBHP and cumene hydroperoxide have also been shown to 
induce radical production in keratinocytes (18). The 
radical process of lipid peroxidation has been shown to be 
inducible in keratinocytes but is unrelated to cell damage 
(19); BPO is cytotoxic to these cells but does not induce 
lipid peroxidation (19). Thus, it might be anticipated 
that BPO can cause cell damage by a mechanism that does not 
involve lipid peroxidation.
We have found that BPO is not readily metabolized by 
mitochondrial glutathione peroxidase and therefore may not
be expected to alter mitochondrial function in the manner 
ascribed to other peroxidic prooxidant promoters. Herein, 
we report the effects of BPO on mitochondrial electron and 
energy transfer and on the morphology of mitochondria.
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MATERIALS AND METHODS
Chemicals. Benzoyl peroxide, N-tert-butvl-aloha- 
phenylnitrone (PBN), and sodium cyanide were purchased from 
Aldrich. ADP, antimycin A, BSA, catalase, carbonyl cyanide 
m-chlorophenylhydrazone (CCCP), beta-hydroxybutyrate (BHB, 
sodium salt), succinate (sodium salt), and superoxide 
dismutase (SOD) were obtained from Sigma. N,N,N',N'- 
Tetramethyl-p-phenylenediamine (TMPD) was from Pfaltz and 
Bauer. 2,4-Dinitrophenol (DNP) was purchased from 
Matheson, Cole and Bell. Dimethyl-l-pyrroline-N-oxide 
(DMPO) was obtained from Sigma and purified by diluting 
with distilled, deionized water, stirring with decolorizing 
carbon for 5 minutes and then filtering. All other 
chemicals were commercial samples of high purity and used 
as supplied. All solutions were made in distilled, 
deionized water. BPO solutions were prepared in 
acetonitrile. Antimycin A, CCCP, and TMPD were all used as 
methanolic solutions.
Preparation of Rat Liver Mitochondria. Adult male 
Sprague-Dawley rats (3 00-400 g) were fasted overnight and 
sacrificed by decapitation. Liver mitochondria were 
isolated by differential centrifugation (20) using 250 mM 
sucrose, 3.4 mM Tris (pH 7.4), 1 mM EGTA, and 0.15% BSA. 
Mitochondria were washed in the same medium without EGTA 
and BSA.
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Preparation of Beef Heart Mitochondria. Beef heart 
mitochondria were isolated by differential centrifugation 
(21) and suspended in 250 mM sucrose, 10 mM Tris-Cl (pH 
7.8), 1 mM sodium succinate, and 2 mM EDTA.
Preparation of Beef Heart Submitochondrial Particles. 
After storing the beef heart mitochondria at -2 0°c for one 
week, the mitochondria were thawed and submitochondrial 
particles were prepared by sonication followed by 
differential centrifugation (22) using 100 mM sodium 
phosphate buffer (pH 7.4).
Determination of Protein Concentration. The protein 
concentrations of the mitochondrial and submitochondrial 
suspensions were determined by the method of Bradford (23) 
using BSA as a standard.
Measurement of Mitochondrial Respiration.
Mitochondrial respiration was determined polarographically 
using a Clark-type electrode. Mitochondria (1.4-5.0 mg of 
protein) were added to 3.0 ml (final volume) of medium 
saturated with air at 3 0°C and containing 80 mM NaCl, 10 mM 
MgCl2 # 4.5 mM sodium phosphate and 5 mM Tris, at a final pH 
of 7.4. Either 5 mM BHB or 5 mM sodium succinate was used 
to initiate state 4 respiration. State 3 respiration was 
initiated by adding 900 nmoles of ADP. Either CCCP (1.6 uM 
final concentration) or DNP (120 uM final concentration) 
were used as uncouplers of oxidative phosphorylation.
Difference Spectroscopy. The redox states of the 
mitochondrial cytochromes were determined in 1 cm cells on 
a Varian Cary 219 uv-visible spectrophotometer in a manner 
similar to that described by Chance and Williams (24). The 
medium used here was the same as that described above for 
the respiration studies. The reference cell contained 
oxidized submitochondrial particles (2 mg of protein - no 
substrate) while the sample cell contained respiring 
submitochondrial particles (2 mg of protein and 10 mM 
sodium succinate, final concentration) treated with either 
antimycin A (2.7 uM, final concentration) or BPO (13 uM, 
final concentration).
Spin Trapping With DMPO in Respiring SMP. 
Submitochondrial particles (2 mg of protein), cytochrome c 
(5.5 nmoles/mg SMP protein) and sodium succinate (10 mM, 
final concentration) were incubated at room temperature for 
one minute with DMPO (100 mM, final concentration) in 
sodium phosphate buffer (33 mM, final concentration, pH 
7.4) prior to the addition of either antimycin A (1.6 uM) 
or BPO (105 uM, final concentration). After a one minute 
incubation in the presence of BPO, the suspension was put 
in a 17 mm flat cell and degassed by vacuum. The flat cell 
was then mounted in the T M n 0 wide-bore cavity at X-band 
frequency. In experiments involving protective enzymes, 
these were added to the reaction mixture prior to the
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addition of the oxidant (final concentrations shown in Fig.
5) .
Spin Trapping With DMPO in Respiring Mitochondria. 
Uncoupled rat liver mitochondria (8 mg protein) were 
incubated at room temperature for one minute with DMPO (50 
mM, final concentration) in a medium containing 80 mM NaCl,
10 mM MgCl2 , 4.5 mM sodium phosphate, 5 mM Tris, at a final 
pH of 7.4. Sodium succinate (40 mM) was added to initiate 
state 4 respiration. BPO (160 uM, final concentration) was 
added to inhibit respiration. After a one minute 
incubation in the presence of BPO, the sample was added to 
a flat cell and treated as described previously.
Spin Trapping With DMPO in Non-Respiring Mitochondria. 
Coupled rat liver mitochondria (10 mg protein) were 
incubated at room temperature for one minute with DMPO (50
mM, final concentration) in a medium containing 0.25 M
sucrose and 3.4 mM Tris at a final pH of 7,4. BPO (2 mM, 
final concentration) was added, and the suspension was 
incubated for one minute. The sample was than added to a 
flat cell and treated as described previously.
Spin Trapping With PBN in Non-Respiring Mitochondria. 
Coupled rat liver mitochondria (10 mg protein) were 
incubated at room temperature for one minute with PBN (50 
mM, final concentration) in a medium containing 150 mM NaCl
and 20 mM Tris at a final pH of 7.4. Either BPO or DMVN
(final concentrations given in Fig. 6) was then added, and
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the suspension was incubated at 37°C for 5 minutes. The 
sample was then added to a flat cell and treated as 
described previously,
HPLC Analysis of Organic Extracts From Mitochondria 
Treated With BPO. Mitochondria (10 mg protein) were added 
to 5.0 ml (final volume) of medium saturated with air at 
25°C and containing 80 mM NaCl, 10 mM MgCl2 , 4.5 mM sodium 
phosphate and 5 mM Tris, all at a final pH of 7.4. BHB (15 
mM, final concentration) was used to initiate state 4 
respiration. State 3 respiration was initiated by adding 
0.45 umoles of ADP. Respiration was inhibited by the 
addition of BPO (0.24 mM, final concentration). Aliquots 
(1.0 ml) were removed from the suspension at 1, 3, 5, and 7 
minutes after the addition of BPO and extracted via Folch 
extraction (25) using 5.0 ml of 2:1 chloroform/methanol.
2.0 ml of the organic layer was evaporated to dryness on a 
rotary evaporator. The residue was dissolved in 1.0 ml of 
80% hexane/20% dichloromethane and filtered through a Xydex 
LID/X filter syringe. BPO "blanks" were prepared by adding 
BPO (0.24 mM, final concentration) to 5.0 ml buffer (see 
above), removing two 1.0 ml aliquots and extracting in the 
same manner as described above. The samples were analyzed 
on a Hewlett Packard 1090 HPLC using a Dupont Zorbax Cyano 
column (4.6 mm X 25 cm) and a solvent system of 80% 
hexane/19% dichloromethane/1% n-propanol at a flow rate of
1.0 ml/min.
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GC/MS Analysis of Organic Extracts From Mitochondria
Treated With BPO. The aqueous layer resulting from Folch 
extraction of BPO-treated mitochondria (see previous 
section) was treated with 1 drop of concentrated 
hydrochloric acid and extracted with 5.0 ml chloroform.
The organic layer was evaporated to dryness on a rotary 
evaporator. The residue was dissolved in 0.5 ml chloroform 
and filtered through a Xydex LID/X filter syringe. The 
samples were analyzed on a Hewlett Packard 5890 GC/MS using 
a DB-17 column (0.179 mm X 20 m ) .
Assay of Glutathione Peroxidase Activity. The 
glutathione peroxidase assay was performed using the 
coupled assay described by Gunzler and Flohe (26). BPO, 
TBHP and hydrogen peroxide were compared as substrates 
(final concentrations given in Table IV).
Mitochondrial Swelling. Coupled rat liver 
mitochondria (ave. RCR = 4.5) were .used for all swelling 
experiments. Mitochondrial suspensions (20 ul - 40 ul) 
containing approximately 0.5 mg protein were diluted with
3.0 ml suspension buffer (150 mM NaCl, 20 mM Tris, pH 7.4) 
to give an initial absorbance of 0.6 to 0.8 at 700 nm. BPO 
was then added to initiate swelling. Swelling was 
monitored by following the decrease in turbidity of a 
dilute mitochondrial suspension at 700 nm on a Cary 219 uv- 
visible spectrophotometer in 1 cm cells at room 
temperature. This method was similar to that described by
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Bhuvaneswaran and Dakshinamurti (27). In experiments 
involving either protective enzymes, radical scavengers or 
sulfhydryl reagents, these agents were added to the 
mitochondrial suspension prior to the addition of BPO 
(final concentrations shown in Figs. 8 , 11 and 12).
Measurement of Lipid Peroxidation bv the TBA Test. 
Peroxidation of mitochondrial membrane lipids was assessed 
by the spectrophotometric determination of TBA-reactive 
products according to the procedure described by Aust (25). 
Coupled rat liver mitochondria (6 mg protein) were added to 
6 ml (final volume) of medium saturated with air at 25°C 
and containing 150 mM NaCl at a final pH of 7.4. A 1.0 ml 
aliquot was removed and added to 2.0 ml of stock TBA-TCA-
HCl reagent (15% w/v TCA, 0.375% w/v TBA, 0.25 N HC1).
Either BPO, TBHP or a mixture of one of these oxidants with
FeS04 was added to the remaining mitochondria (final
concentrations given in Fig. 9). Aliquots (1.0 ml) were 
removed at 5, 10, 15, and 30 minutes following the addition 
of the initiator and added to stock TBA-TCA-HC1 reagent.
The samples were placed in a boiling water bath for 15 
min., cooled and centrifuged to remove the precipitate 
formed during boiling. The absorbance of the samples was 
measured at 532 nm on a Hewlett Packard UV-visible 
spectrophotometer against a blank that contained all the 
reagents but no mitochondria.
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RESULTS AND DISCUSSION
BPO Inhibition of Mitochondrial NADH Oxidase and 
Succinoxidase. Fig. 1 is a composite of several 
experiments showing the effects of varying concentrations 
of BPO on mitochondrial beta-hvdroxvbutvrate oxidase (Fig.
1A) and succinoxidase (Fig. IB) activities. The addition 
of BPO during state 3 respiration (ADP-limiting) results in 
rapid inhibition of oxygen uptake. The uncoupling agent 
dinitrophenol (DNP) results in a partial release of the 
inhibition of state 3 respiration. This effect is 
dependent upon the concentration of BPO; at a final 
concentration of 15 uM BPO, DNP has little effect on the 
rate of respiration while at 7.4 uM BPO, the DNP- 
stimulated rate is similar to that seen in the absence of 
BPO. Similar results are observed with carbonyl cyanide m- 
chlorophenylhydrazone (CCCP), which is an even more potent 
uncoupling agent than DNP. Using CCCP, the effects of BPO 
on uncoupler-stimulated respiration are shown in comparison 
to those of the classical chain inhibitor antimycin A and 
the ATPase inhibitor oligomycin A (Table I). When 
antimycin A is added to mitochondria at concentrations 
sufficient to cause >90% inhibition of mitochondrial state 
3 respiration, little to no stimulation of oxygen uptake is 
observed upon the addition of CCCP (Table I). When 
oligomycin A is added to mitochondria at concentrations 
sufficient to cause 80% inhibition of mitochondrial state 3
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Figure 1: Titration of BHB-respiring mitochondria (Panel A) and 
succinate-respiring mitochondria (Panel B) with BPO. The composite 
curves consist of a series of superimposed records of individual 
experiments in which the final concentration of BPO was varied from 
0 to 15 uM (actual concentrations shown in figure). All other 
concentrations were maintained constant. Mitochondria (2.0 mg of 
protein) were added to 3.00 ml (final volume) of buffer (80 mM NaCl, 
10 mM MgCl2 , 4.5 mM sodium phosphate, 5 mM Tris, pH 7.4) and the 
oxygen uptake was measured with a Clark-type oxygen electrode at 
30°C. BHB was used to stimulate state 4 respiration in the study of 
NADH-linked respiration while sodium succinate was used in the study 
of FADH2-linked respiration. ADP was used to stimulate state 3 
respiration. DNP was used to test its effect in releasing the 
respiratory inhibition caused by BPO. The point of addition of 
these compounds is indicated in the figure by arrows. The final 
concentrations of the additives were as follows: BHB, 5 mM; sodium 
succinate, 5 mM; ADP, 300 uM; DNP, 120 uM.
Table I: Release of BPO Inhibition of Mitochondrial Respiration by CCCP.3
nmoles of 0 per min per mg protein % Stimulation of
______________________________  Difference in % Respiration by CCCP
Inhibn (State 3 - over Corresponding 
Inhibitor +ADP %Inhibn +CCCP %lnhibn CCCP Uncoupled) State 3 Value
None 69+6 71+3 3
BPO (13 uM) 6.5+>3 91 27+3 62 29 315
BPO (20 uM) 4.6+,3 93 8.4+.S 88 5 83
BPO (26 uM) 4.8+1.9 93 7.2+.9 90 3 50
Anti A (48 nM) 9.5+3.3 86 22+11 69 17 132
Anti A (64 nM) 5.6+>l 92 7.3+.5 90 2 30
Anti A (128 nM) 5.4+1.0 92 5.6+1.3 92 0 4
Olig A (1.4 uM) 14+1 80 78+8 -7 87 457
aMitochondria (2.4 mg of protein) were suspended in 3.00 ml (final volume) of buffer (80 
mM NaCl, 10 mM 4.5 mM 5 mM Tris, pH 7.4) and the oxygen uptake was measured
with a Clark-type oxygen electrode at 30°C. The final concentrations of the additives were as 
follows: BHB, 5 mM; ADP, 300 uM; CCCP, 1.6 uM. The abbreviations Anti A and Olig A refer to 
antimycin A and oligomycin A respectively. The control values are an average of four 
determinations + standard deviation while the values for the inhibitors are an average of two 
determinations + average deviation. The negative value given for % inhibition by oligomycin A 
in the presence of CCCP refers to stimulation of oxygen uptake to a greater rate than the 
control value.
65
respiration, complete reversal of inhibition is observed 
upon the addition of CCCP (Table X). At concentrations 
that cause >90% inhibition of state 3 respiration, the 
effect of BPO is found to be intermediate between that of 
antimycin A and oligomycin A. These data indicate that BPO 
interacts with components of both the mitochondrial 
electron-transport chain and of the energy-producing 
assemblies.
As shown in Fig. 2, the inhibition of state 3 
mitochondrial respiration by BPO is concentration dependent 
for both NADH-linked respiration (open symbols) and FADH2- 
linked respiration (closed symbols). The concentration of 
BPO necessary to suppress respiration to 50% of uninhibited 
controls (IC5 0 ) is essentially equal for inhibition of both 
NADH- and FADH2 ~linked respiration by BPO. The similarity 
of these IC50 values suggests that BPO inhibits both NADH- 
oxidase and succinoxidase to a similar extent or that 
inhibition occurs at a site distinct from these complexes. 
Thus, inhibition may occur at or on the oxidase side of 
coenzyme Q (Fig. 3).
Reversal of BPO Inhibition by TMPD■ When TMPD is 
added to respiring submitochondrial particles (SMP) 
inhibited by either antimycin A or BPO, an immediate 
stimulation of respiration is observed (Table II). This 
observation generally is taken to indicate a respiratory 
block on the substrate side of ferricytochrome c, as TMPD
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Figure 2: Inhibition of NADH- and FADH2-linked respiration by BPO as 
a function of the concentration of mitochondrial protein. Different 
symbols indicate different mitochondrial preparations. The open 
symbols are for inhibition of NADH-linked respiration while the 
closed symbols are for inhibition of FADH2-linked respiration. The 
values for % inhibition are calculated by dividing the inhibited 
rate of respiration by the uninhibited rate of respiration (state 3 
rate). Protein concentration ranged between 0.5 and 1.7 mg per ml. 
Experimental conditions as in Figure 1. IC50 values for the two 
curves were determined by nonlinear regression analysis using a 
logarithmic algorithm.
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Figure 3: The mitochondrial electron transport chain.
Table II: Effect of the Electron Shunt TMPD on the Rate of Submitochondrial Particle 
Respiration During Inhibition Induced by Either Antimycin A or Benzoyl Peroxide.3
Inhibitor
nmoles of 0 per min per mg protein
+Succinate +Inhib. +TMPD +NaCN
% Stimulation 
of Respiration 
by TMPD over 
Inhibited value
% Inhibition 
of Respiration 
by NaCN over 
SMPD Value
None 89+6 10518 3.512.0
BPO 76+1 4.41.5 4211 3.4+0.3 855 92
Anti A 74+4 4.61.4 46+16 2.8+0.6 900 94
aSubmitochondrial particles (0.5 mg of protein) were suspended in 3.00 ml (final 
volume) of buffer (80 mM NaCl, 10 mM MgC^, 4.5 mM Na^HPC^, 5 mM Tris, pH 7.4) and the 
oxygen uptake was measured with a Clark-type oxygen electrode at 30°C. The final 
concentrations of the additives were as follows: sodium succinate, 5 mM; TMPD, 0.3 mM; 
NaCN, 1 mM; BPO, 6.7 uM; antimycin A, 0.2 uM. Each value is an average of two 
determinations + average deviation.
is known to donate electrons to cytochrome c (28). The 
TMPD-bypassed respiration of either the antimycin A-blocked 
or BPO-blocked respiratory chain is inhibited by cyanide, 
an inhibitor of cytochrome oxidase. BPO is a potent 
oxidant that reacts directly with TMPD (unpublished 
results). In the SMP system, this reaction may lead to 
destruction of the BPO with subsequent release of 
respiratory inhibition. Although this reaction could not 
be rigorously excluded, the fact that cyanide inhibits 
TMPD-stimulated oxygen uptake indicates that BPO does not 
irreversibly damage or inhibit cytochrome oxidase.
Effect of BPO on the Redox States of Mitochondrial 
Cytochromes. When BPO is added to succinate-respiring SMP, 
only the major alpha and gamma (Soret) bands of reduced 
cytochrome b are observed to accumulate in the difference 
spectrum (reduced minus oxidized) in a manner analogous to 
that observed in the presence of antimycin A (Fig. 4).
This result indicates that BPO inhibits the flow of 
electrons from the substrate side of cytochrome c.
Although antimycin A and BPO both cause an accumulation of 
reduced cytochrome b, this result does not necessarily mean 
that they inhibit the electron transport chain at the same 
site. According to the mechanism of the protonmotive Q 
cycle (29), antimycin A inhibits reoxidation of cytochrome 
b-562. BPO may act in a similar manner or it may interact
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Figure 4: Difference spectrum of respiring submitochondrial 
particles treated with either antimycin A (Panel A) or BPO (Panel
B). Submitochondrial particles (2.0 mg of protein) were added to
1.50 ml (final volume) of buffer (80 mM NaCl, 10 mM MgCl2, 4,5 mM
sodium phosphate, 5 mM Tris, pH 7.4) in each of two cells. Sodium
succinate (10 mM, final concentration) and either antimycin A (2.7 
uM, final concentration) or BPO (13 uM, final concentration) were 
added to the sample cell. The difference spectrum was measured at 
25°C on a Cary 219 UV-visible spectrophotometer.
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with the iron-sulfur protein that donates electrons to 
cytochrome C]_,
Action of Antimycin A and BPO on Radical Production in 
Submitochondrial Particles. Respiring mitochondria have 
been shown to produce superoxide radicals via redox cycling 
of the coenzyme Q semiquinone free radical (30). The 
production of superoxide radicals is stimulated in the 
presence of antimycin A (30) and steady state 
concentrations of 02" and H2 02 are established (31). 
Superoxide and hydroxyl radicals can be detected by ESR 
from respiring beef heart mitochondria treated with 
antimycin A in the presence of the spin trap 5,5-dimethyl- 
1-pyrroline-N-oxide (DMPO) (32). We have obtained similar 
results with respiring SMP using either antimycin A (Fig.
5A) or BPO (Fig. 5D) as a respiratory chain inhibitor.
When antimycin A is added to succinate-respiring SMP 
in the presence of the spin trap DMPO, an ESR spectrum 
resulting from the trapping of two radical intermediates is 
observed (Fig. 5A). The major, four-line spin adduct has 
hyperfine splitting constants (hfsc) of a^ = an = 1.49 mT, 
consistent with a hydroxyl radical spin adduct (33). The 
hfsc of the other adduct could not be measured due to the 
weakness of this signal, although the adduct has been 
tentatively identified as the superoxide radical spin 
adduct by comparison of the experimental spectrum with a 
gaussian simulation of both adducts (Fig. 5B). Our
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Figure 5: Effect of protective enzymes on BPO-induced radical 
production in respiring submitochondrial particles.
(A) Incubation containing SMP (2.0 mg of protein), 5.5 nmoles 
cytochrome c per mg protein, 10 mM sodium succinate, 100 mM DMPO, 
and 1.6 uM antimycin A in buffer (0.1 M sodium phosphate, chelexed, 
pH 7.4). (B) Gaussian simulation of the DMP0-0H and DMPO-OOH 
adducts. (C) Same as in A except that no antimycin A was present.
(D) Incubation containing SMP (2,0 mg of protein), 5.5 nmoles 
cytochrome c per mg protein, 10 mM sodium succinate, 100 mM DMPO, 
and 105 uM BPO in buffer (0.1 M sodium phosphate, chelexed, pH 7.4).
(E) Same as in D except 100 ug per ml of SOD was present. (F) Same 
as in D except 1000 ug per ml of catalase was present. (G) Same as 
in D except 100 ug per ml of SOD and 1000 ug per ml of catalase were 
present. These ESR experiments were carried out on an IBM 
Instruments model ER200-SRC spectrometer equipped with an Aspect 
2000 data system. The following instrument conditions were used: 
microwave power, 20 mW; modulation amplitude, 1.25 G; receiver gain, 
2 X 10®; time constant, 500 ms; sweep width, 90 G; sweep time, 200 
s; number of scans, 2.
experimental hfsc values for the hydroxyl adduct (given 
above) and values for the hfsc of the DMPO-superoxide 
adduct (ajj = 1.42 mT, ajj = 1.13 mT, and ajj = 0.13 mT) 
formed by the xanthine/xanthine oxidase system (unpublished 
results) have been used to generate the simulated spectrum. 
No significant radical production is observed with 
respiring SMP in the absence of antimycin A (Fig. 5C). 
Addition of superoxide dismutase (SOD) to the SMP 
suspension prior to the addition of BPO results in a 
reduction in the intensity of both the hydroperoxyl and 
hydroxyl spin adduct (Fig. 5E). The reduction in the 
intensity of both the DMP0-00H and DMPO-OH adducts by SOD 
suggests that some hydroxyl adduct formation is due to 
decomposition of the DMP0-00H adduct (34). Catalase causes 
attenuation of only the hydroxyl adduct signal (Fig. 5F), 
indicating that some of the DMPO-OH adduct results from 
direct trapping of the H2 0 2~derived hydroxyl radical. 
Addition of both catalase and SOD results in complete 
inhibition of both the DMPO-OOH and DMPO-OH signals (Fig. 
5G). The fact that oxygen radical production is increased 
when respiring SMP are treated with BPO in the presence of 
DMPO is consistent with inhibition of electron flow by BPO 
at a locus after coenzyme Q in the electron transport 
chain. Furthermore, BPO does not yield spin-trappable 
radicals in non-respiring SMP, indicating that the observed 
radical- production in respiring SMP must be related to
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electron transport and not to radicals generated via the 
decomposition of BPO.
Action of BPO on Radical Production in Intact 
Mitochondria. tert-Butyl hydroperoxide, another free 
radical initiator, induces the production of spin-trappable 
radicals in both respiring and non-respiring rat liver 
mitochondria (16) . BPO does not yield spin-trappable 
radicals when added to intact liver mitochondria (respiring 
or non-respiring) in the presence of DMPO. This spin trap 
partitions significantly into the aqueous phase. Thus, 
radicals generated in the lipid bilayer of the 
mitochondrial membrane may not be trapped by DMPO. To 
investigate this possibility, mitochondria have been 
incubated at 37°C in the presence of PBN, a more lipophilic 
spin trap, and BPO for 5 minutes. Following this 
incubation, no ESR spin adducts are observed (Fig. 6A). 
2,2'-Azo-bis(2,4-dimethylvaleronitrile) (DMVN) has been 
used to confirm that radicals can be generated in 
mitochondria via thermal decomposition of a free radical 
initiator. When DMVN is substituted for BPO, spin adducts 
attributable to both a carbon-centered and oxygen-centered 
adduct are observed (Fig. 6B). The carbon-centered adduct 
has measured hfsc of aN = 1.53 mT and an = 0.33 mT while 
the oxygen-centered adduct has measured hfsc of a^ = 1.40 
mT and ajj = 0.20 mT. The inability of BPO to yield 
radicals in mitochondria may be due to loss of this.
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Figure 6: Initiator-induced radical production in non-respiring 
liver mitochondria. (A) Incubation containing mitochondria (5.0 mg 
protein), 47 mM PBN, and 9.4 mM BPO in buffer (0.15 M NaCl, 0.02 M 
Tris, pH 7.4). (B) Same as in A except that 9.4 mM DMVN was present
instead of BPO. These ESR experiments were carried out on an IBM 
Instruments model ER100D spectrometer equipped with an Aspect 2000 
data system. The following instrument conditions were used: 
microwave power, 20 mW; modulation amplitude, 0.63 G; receiver gain, 
8 X 10^; time constant, 200 ms; sweep width, 90 G; sweep time, 200 
s; number of scans, 3,
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compound via induced decomposition (35,36), which results 
in low efficiency of radical production in polar solvents.
Fate of BPO Purina Inhibition of Respiration. Table 
III shows the amount of BPO recovered by organic extraction 
after one minute from typical mitochondrial incubations. 
Essentially all of the BPO disappears in the presence of 
both respiring and non-respiring mitochondria. With heat- 
denatured mitochondria, approximately 25% of the BPO still 
remained after one minute of incubation. This residual BPO 
disappeared completely over the next two minutes. Even 
though heat denaturation of the mitochondrial enzymes slows 
BPO disappearance, the disappearance is still accelerated; 
in the absence of mitochondria, no loss of BPO is observed 
over longer time periods. Despite the rapid loss of HPLC- 
detectable BPO in the presence of mitochondria, intact or 
not, no BPO derived-products are observed in organic 
extracts of mitochondria, suggesting tight binding or 
sequestration. However, benzoate, a product of the induced 
decomposition of BPO (35,36), would be found in the aqueous 
layer following extraction of BPO-treated mitochondria.
The presence of benzoate has been probed by treating the 
aqueous layer with acid, extracting with chloroform and 
analyzing the extract by GC/MS. By this method, we have 
determined that benzoate is formed when mitochondria are 
treated with BPO. Thus, the loss of BPO over time can be
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Table III: Amount of BPO Recovered From Buffer 
and Mitochondria by Organic Extraction.a
Type of Incubation nmoles of BPO Extracted
Buffer 203+2
Respiring Mitochondria 1.3+0.1
Non-Respiring Mitochondria 3.9+0.2
Heat Denatured Mitochondria 49+3
aMitochondria (10.0 mg of protein) were suspended in 5.0 ml 
(final volume) of buffer (80 mM NaCl, 10 mM MgCl2, 4.5 mM Na2HF04, 5 
mM Tris, pH 7.4) at 25°C. The final concentrations of the additives 
were as follows: BHB, 15 mM; ADP, 0.90 mM; BPO, 0.24 mM. BHB and 
ADP were added in the respiring mitochondria incubation only. 
Mitochondria were denatured by heating for two minutes in a boiling 
water bath. Extraction and analysis of samples as described under 
Methods. Each value is an average of two determinations + average 
deviation.
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attributed, at least in part, to the conversion of BPO to 
benzoate.
Effect of BPO on the Turbidity of Mitochondrial 
Suspensions. Lysis of the mitochondrial membrane is often 
a consequence of mitochondrial swelling (37). Because 
other peroxidic compounds are known to cause mitochondrial 
swelling, the effects of BPO on mitochondrial swelling have 
been studied.
The addition of BPO to non-respiring rat liver 
mitochondria results in rapid, large-amplitude swelling.
The rate and amplitude of swelling is dependent on the 
ratio of BPO to mitochondrial protein but is independent of 
respiratory substrate (Fig. 7). BPO-induced mitochondrial 
swelling appears to be independent of endogenous calcium, 
as neither ruthenium red, a calcium channel blocker, nor 
EGTA, a calcium chelator, altered the rate of swelling when 
incubated with mitochondria prior to the addition of BPO. 
These results suggest that the mechanism of BPO-induced 
swelling is different than that of hydroperoxide-induced 
swelling, which is dependent on calcium cycling. 
Hydroperoxide-induced swelling is also dependent upon the 
ability of the hydroperoxide to serve as a substrate for 
glutathione peroxidase (13-15). The data in Table IV show 
that under conditions in which TBHP and H2O2 readily 
promote glutathione peroxidase activity (38), BPO is 
ineffective. This lack of activity provides further
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Figure 7: Induction of mitochondrial swelling by BPO. The composite 
curve consists of a series of superimposed records from individual 
experiments in which the amount of BPO added was varied. The 
numbers next to the curves refer to amount of BPO added in units of 
nmoles BPO/rag mitochondrial protein. Mitochondria (0.50 mg of 
protein) were added to 3.00 ml buffer (0,15 M NaCl, 0.02 M Tris, pH 
7.4). The change in optical density of the mitochondria was 
monitored at 25°C on a Cary 219 UV-visible spectrophotometer set at 
700 nm.
Table IV: Activity of Peroxides as Substrates for Glutathione Peroxidase.3
NADPH Oxidation in umole/l/sec
Peroxide NADPH
NADPH + GSH + 
GSSG Reductase
NADPH + GSH + 
GSSG Reductase + 
GSH Peroxidase
Ratio of 
Catalyzed to 
Dncatalyzed
Relative
Activity
Ncne 0.05+0.005 0.03+0.002 0.09+0.02 3 —
0.1 itH H2O2 — 0.06+0.002 1.18+0.03 20 100
1.0 mM TBHP -- 0.10+0 .OOj 1.36+0.03 14 70
0.1 mM BPO 0.09+0.01 0.34+0.09b 0.50+0,08b 1.5 7.5
0.2 mM BPO 0.19+0.02 1.08+0.06b 1.08+0.18b 1.0 5.0
aThe assay was carried out in phosphate buffer (1 irM EDTA, 0.1 H sodium phosphate, pH 7.0) 
at 37°C. The oxidation of NADPH was monitored at 340 nm on a HP UV-visible spectrophotometer. 
The final concentrations of the reactants were as follows: NADPH, 0.15 mM; GSH, 1.0 mM; GSSG 
reductase, 0.24 units per ml; GSH peroxidase, 0.10 unit per ml. Each value is an average of 
three determinations +. standard deviation.
^These are initial rates of NADPH oxidation, as the change in absorbance at 340 nm in 
these experiments was non-linear with time.
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evidence that BPO induces swelling by a different mechanism 
than does TBHP.
Determination of the Role of Free Radicals in the 
Mechanism of BPQ-Induced Swelling. Glutathione peroxidase, 
catalase and SOD do not cause any significant inhibition of 
BPO-induced mitochondrial swelling. Thus, either swelling 
is not oxygen radical-dependent or the site of production 
and reaction of these oxyradical species is inaccessible to 
the protective enzymes. The radical scavenger sodium 
benzoate also has no effect on BPO-induced swelling (Fig.
8), implying that free hydroxyl radicals are not involved 
in the process. GSH and alpha-tocopherol (a-T) 
significantly inhibit BPO-induced mitochondrial swelling 
(Fig. 8). We have studied the reaction between BPO and GSH 
and have found that these compounds react rapidly to cause 
the oxidation of GSH to GSSG (unpublished results). BPO 
also reacts directly with a-T (39,40). Thus, the 
inhibition of mitochondrial swelling with GSH and a-T may 
be due to the destruction of BPO via direct reaction with 
these compounds. As described previously, BPO does not 
induce the production of spin-trappable radicals in whole 
mitochondria as determined by ESR (Fig. 6A). Surprisingly, 
the data in Fig. 9 show that BPO does induce the production 
of TBA reactive compounds (41), although the concentration 
of products is low when compared to either a TBHP/Fe2+ or 
BPO/Fe2+ initiating system. Ferrous ions enhance the
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Figure 8: Effect of Radical Scavengers on BPO-induced Mitochondrial 
Swelling. Experimental conditions as in Figure 7. Scavengers were 
incubated with mitochondria for 2 min prior to addition of BPO. The 
final concentrations of the additives were as follows: BPO, 33 uM; 
GSH, 100 uM; a-T, 100 uM; sodium benzoate, 100 uM.
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Figure 9: Malondialdehyde Formation in Mitochondria Incubated With 
Peroxidic Initiating Systems. The initiators were added to 5.0 mg 
mitochondrial protein in 0.15 M NaCl at 25°C. 1.0 ml aliquots were
removed from the suspension and treated in the manner described 
under Methods. The final concentrations of the initiators were as 
follows: (A) BPO, 0.2 mM; FeS04, 0.8 mM; (B) TBHP, 0.8 mM; FeSO^
0.8 mM; (C) BPO, 0.2 mM; (D) TBHP, 0.8 mM. Each value is an average 
of three determinations + average deviation.
ability of BPO to induce mitochondrial lipid peroxidation 
(Fig. 9). It would be expected that if lipid peroxidation 
is involved in BPO-induced mitochondrial swelling, then 
ferrous ions should similarly stimulate swelling. However, 
when mitochondria are treated with FeS04 and BPO, a 
significant reduction in the rate of BPO-induced swelling 
is observed (Fig. 10). These results indicate that the 
swelling observed with BPO alone is not due to lipid 
peroxidation. Furthermore, we have determined that BPO- 
induced swelling is independent of molecular oxygen; the 
rate and magnitude of swelling determined in suspension 
buffer purged with argon for up to 2 hours prior to the 
addition of mitochondria and BPO is the same as that found 
in the presence of 02- Therefore, any oxidative reactions 
that occur when BPO is added to mitochondria probably 
reflect direct reaction of BPO with mitochondrial 
components.
Determination of the Role of Mitochondrial Sulfhvdrvl 
Groups in the Mechanism of BPO-induced Swelling. Oxidation 
of mitochondrial sulfhydryl groups has been implicated in 
the mechanism by which chlorinated napthoquinones induce 
mitochondrial swelling (42,43). To determine whether 
oxidation of mitochondrial sulfhydryl groups is involved in 
BPO-induced swelling, the effect of several thiol reagents 
have been examined (Fig. 11). Addition of either cysteine, 
DTT, GSH or mercaptoethanol at 200 nmoles thiol/mg protein
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Figure 10: Effect of Ferrous Ions on BPO-induced Mitochondrial 
Swelling. Experimental conditions as in Figure 7. FeS04 and BPO 
were added to the mitochondria at the same time. The final 
concentrations of the additives were as follows: BPO, 39 uM; FeSO^, 
133 uM.
86
0.7
05
oo
K
0.3
0.1
2 4 6 8
TIME (MIN)
Figure 11: Effect of Thiols on BPO-Induced Mitochondrial Swelling. 
Experimental conditions as in Figure 7 except that 0.52 mg of 
mitochondria were used. Thiols were incubated with mitochondria for 
2 rain, prior to addition of BPO. The final concentration of BPO was 
held constant at 33 uM. The final concentrations of the thiols were 
as follows: (A) cysteine, 33 uM; (B) DTT, 33 uM; (C) methionine,
0.32 mM; (D) mereaptoethanol, 33 uM; (E) methionine, 33 uM; (F)
GSSG, 0.32 mM; (G) no thiol added.
results in significant inhibition of swelling. On a per 
mole basis, cysteine and GSH are more effective inhibitors 
than are DTT and mercaptoethanol. A much larger amount of 
methionine (2 000 nmoles/mg protein) is necessary to observe 
inhibition of swelling. Oxidized glutathione (GSSG) does 
not protect against BPO-induced mitochondrial swelling, 
indicating that oxidizable sulfur is necessary to inhibit 
swelling. Taken as a whole, the inhibition of swelling by 
thiol reagents suggests that mitochondrial sulfhydryl 
groups are oxidized during BPO-induced swelling.
More rigorous proof would be direct measurement of 
mitochondrial sulfhydryl groups. We have attempted this 
using both Ellman's reagent (44) and NEM (45). 
Unfortunately, BPO oxidizes the 3-carboxyl-4-nitrophenol 
sulfide ion that is formed from the reaction between DTNB 
and reduced thiols and thus, interferes with the Ellman 
assay (unpublished results). in the NEM method, a water- 
soluble mitochondrial component that absorbs near the NEM 
peak interferes with its measurement (unpublished results).
Reagents that derivatize endogenous thiols, DTNB, NEM, 
PMB and mersalyl, have no significant effect on BPO-induced 
mitochondrial swelling (Fig. 12), suggesting that oxidation 
of mitochondrial sulfhydryl groups is not the rate-limiting 
step in this swelling.
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Figure 12: Effect of Sulfhydryl Group Reagents on BPO-induced 
Mitochondrial Swelling. Experimental conditions as in Figure 7.
All sulfhydryl group reagents were incubated with mitochondria for 8 
min. prior to the addition of BPO except for PMB which was incubated 
for 2 min. There was no incubation period prior to addition of BPO 
in the control experiment where no sulfhydryl group reagent was 
used. The final concentration of BPO was held constant at 33 uM.
The final concentrations of the sulfhydryl group reagents were as 
follows: (A) no sulfhydryl group reagent added; (B) DTNB, 81 uM; (C) 
NEM, 33 uM; (D) PMB; 17 uM; (E) mersalyl, 81 uM.
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Determination of the Role of Monovalent Cations and
Ionic Strength in the Mechanism of BPO-induced Swelling. 
Very slow, low-amplitude swelling is observed when the 
mitochondrial experiments are conducted in an isotonic 
sucrose medium (Fig. 13). The rate and amplitude of 
swelling increase when mitochondria are suspended in a 
solution containing either Na+ or Cs+ and then treated with 
BPO (Fig. 13), indicating that the presence of monovalent 
cations are required for rapid, large-amplitude swelling. 
The fact that swelling is similar in the presence of either 
Na+ or Cs+ shows that BPO-induced mitochondrial swelling is 
not monovalent cation specific. The osmotic nature of this 
swelling has been further investigated as a function of 
varying ionic strength (Fig. 14). When the ionic strength 
of the suspension medium is increased from 0.15 M NaCl to
0.17 M NaCl, an increase in the amplitude of BPO-dependent 
swelling is observed. A further increase in amplitude and 
decrease in the induction period prior to the onset of 
swelling are seen when the mitochondria are suspended in
0.15 M NaCl, 20 mM Tris (pH 7.4). Taken as a whole, the 
osmoregulation studies suggest that BPO initiates passive 
osmotic swelling in mitochondria that is dependent on the 
presence of monovalent cations and on the ionic strength of 
the swelling medium.
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Figure 13: Effect of Monovalent Cations in the Suspension Medium on 
BPO-induced Mitochondrial Swelling. Experimental conditions as in 
Figure 7 except that mitochondria (0.52 mg of protein) were added to 
either (A) 3.00 ml sucrose solution (0.25 M, unbuffered), (B) 3.00 
ml NaCl solution (0.15 M, unbuffered) or (C) 3.00 ml CsCl solution 
(0.15 M, unbuffered). The final concentration of BPO was held 
constant at 33 uM.
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Figure 14: Effect of Ionic Strength on BPO-induced Mitochondrial 
Swelling. Experimental conditions as in Figure 7 except that 
mitochondria (0.52 mg protein) were added to either (A) 3.00 ml NaCl 
solution (0.15 M, unbuffered), (B) 3.00 ml NaCl solution (0.17 M, 
unbuffered) or (C) 3.00 ml suspension buffer (0.15 M NaCl, 0.02 M 
Tris, pH 7.4). The final concentration of BPO was held constant at 
33 uM.
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Effect of Sodium Benzoate and Benzoic Acid Anhydride
on Mitochondrial Respiration and Morphology of 
Mitochondria. Benzoate anion is formed when mitochondria 
are treated with BPO; therefore, the effect of sodium 
benzoate on mitochondrial respiration has been tested to 
determine if it is involved in the mechanism by which BPO 
alters mitochondrial function. At concentrations that 
produce >90% inhibition of state 3 respiration by BPO, 
sodium benzoate is non-inhibitory. At concentrations that 
result in a maximal rate of mitochondrial swelling by BPO, 
sodium benzoate has no effect. Thus, the effects of BPO on 
mitochondrial function described herein are not caused by a 
decomposition product of BPO.
Benzoic acid anhydride is structurally similar to BPO 
except that the carbonyl groups are bridged by a single 
oxygen atom rather than by dioxygen. Inhibition of 
mitochondrial respiration and induction of mitochondrial 
swelling are observed with benzoic acid anhydride; however, 
ten times the concentration of the anhydride is reguired to 
produce approximately one half the effect seen with BPO. 
These results suggest that the dioxo bridge of BPO is 
important in the mechanism by which BPO affects 
mitochondrial function.
Summary. Our results show that BPO inhibits rat liver 
mitochondrial electron transport at coupling site II and 
interacts with a component of the energy-producing
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assemblies. Inhibition of respiration leads to radical 
production in respiring SMP, although these radicals are 
apparently scavenged in intact respiring mitochondria. BPO 
also induces dose-dependent, rapid, large-amplitude 
swelling of mitochondria that is independent of the 
presence of calcium, oxygen and respiratory substrate.
This swelling does not appear to be a radical process but 
instead a reaction of BPO at a specific locus resulting in 
passive osmotic swelling that is dependent on the presence 
of monovalent cations.
The effects of BPO on mitochondria described herein 
are reminiscent of the effects of BPO on keratinocytes 
(19), in which damage occurs via a non-radical mechanism. 
Whether or not the impairment of mitochondrial function is 
an important event in carcinogenesis remains to be 
established. However, the fact that organic peroxide tumor 
promoters (BPO, TBHP, cumene hydroperoxide) all produce 
alterations in the ultrastructure of the mitochondrion 
suggests that impairment of mitochondrial function may be a 
common theme in peroxide-mediated tumor promotion, albeit 
by different mechanisms.
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ABSTRACT
When isolated rat liver mitochondria are treated with 
tert-butyl hydroperoxide in the presence of the spin trap 
5,5-dimethyl—1-pyrroline-N-oxide, a six-line ESR signal is 
observed with parameters characteristic of a carbon- 
centered radical. The radical is shown to be CH3 * using 2- 
methyl-2-nitrosopropane as the spin trap. Inhibition of 
radical production by EDTA and N-ethylmaleimide provides 
evidence for participation by metals and reduced sulfhydryl 
groups in the radical-generating reaction. It is proposed 
that radicals are formed through the reaction between a 
reducing agent, a metal and the hydroperoxide.
ABBREVIATIONS
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ESR, electron-spin resonance; DMPO, 5,5-dimethyl-1- 
pyrroline-N-oxide; EGTA, [ethylenebis- 
(oxyethylenenitrilo)] tetraacetic acid; HEPES, 4-(2- 
hydroxyethy1)-1-piperazineethanesulfonic acid, MNP, 2- 
methyl-2-nitrosopropane; NEM, N-ethylmaleimide; TBHP, tert- 
butyl hydroperoxide.
INTRODUCTION
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The role of free radicals in the hydroperoxide-induced 
damage of rat liver mitochondria has been controversial. 
Some groups attribute the swelling observed when 
mitochondria are treated with hydroperoxides to lipid 
peroxidation initiated by radicals arising from the 
decomposition of the hydroperoxide (1 ); the initial event 
in this process may be a reaction between the hydroperoxide 
and cytochrome P-450 (2). Other groups have suggested that 
the swelling and loss of membrane potential in Ca2+-loaded 
rat liver mitochondria is due to induction of Ca2+ cycling 
(3), which may be a non-radical process dependent upon 
pyridine nucleotide oxidation (4,5). It is surprising, 
therefore, that no attempt has been made to directly detect 
the formation of radicals from the interaction of 
hydroperoxides with mitochondria.
We here report a study of the action of tert-butyl 
hydroperoxide (TBHP) on rat liver mitochondria using the 
ESR spin trapping method to determine whether radicals are 
produced in this interaction. Spin trapping has been used 
to study the production of hydroxyl radicals in respiring 
rat heart mitochondria (6 ). With both Ca2+-deficient, non­
respiring mitochondria and Ca2+-loaded, respiring 
mitochondria, we find that methyl radicals are produced 
upon incubation with TBHP. It is proposed that radicals
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are generated by a metal-mediated reaction between an 
endogenous reducing agent (either GSH or ascorbate) and 
TBHP.
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MATERIALS AND METHODS
Chemicals■ TBHP (70%), and 2-methyl-2-nitrosopropane 
(MNP) were used as obtained from Aldrich. 5,5-Dimethyl-l~ 
pyrroline N-oxide (DMPO) was obtained from Sigma and 
purified by diluting with distilled, deionized water, 
stirring with decoloring carbon for 5 minutes and then 
filtering. All other chemicals were commercial samples of 
high purity and were used as supplied.
Preparation of Rat Liver Mitochondria. Adult male 
Sprague-Dawley rats (290-350 g) were fasted overnight and 
sacrificed by decapitation. Liver mitochondria were 
isolated by differential centrifugation (7) using 210 mM 
mannitol, 70 mM sucrose, 5 mM HEPES (pH 7.4), 1 mM EGTA, 
and 0.15% bovine serum albumin (BSA). Mitochondria were 
washed in the same medium without EGTA and BSA.
Determination of Protein Concentration. The protein 
concentration of the final mitochondrial suspension was 
determined by the method of Lowry, et al. (8 ) using BSA as 
a standard.
ESR Spin Trapping in Mitochondria. Mitochondria (7.7- 
10.7 mg mitochondrial protein) were incubated at room 
temperature for one minute with either DMPO (48 mM, final 
concentration) or MNP (55mM, final concentration) in HEPES 
buffer (210 mM mannitol, 70 mM sucrose, 5 mM HEPES, pH 7.4) 
prior to the addition of TBHP (final concentrations shown 
in figure legends). After a one minute incubation in the
presence of the oxidant, the suspension was put in a 17 mm 
flat cell and degassed by vacuum. The flat cell was then 
mounted in the TM]_io wide-bore cavity for ESR measurements 
at X-band frequency. In some experiments, the mitochondria 
were solubilized in 20-100 uL of Triton X-100 before the 
DMPO was added. In experiments with Ca2+-loaded, respiring 
mitochondria, the incubation medium contained 24 mM 
succinate, 25 uM rotenone, and 1.3 mM CaCl2 . When additives 
(i.e., NEM and EDTA) were used, these compounds were added 
to the reaction mixture prior to the addition of the 
oxidant (final concentrations shown in Table 1). Anaerobic 
and aerobic incubations were performed by stirring under 
either nitrogen or air for 10 minutes prior to degassing 
and ESR measurement.
RESULTS AND DISCUSSION 
Identification of Radicals Produced by TBHP in
Mitochondria. When non-respiring, Ca2+-deficient rat liver 
mitochondria are treated with TBHP in the presence of the 
spin trap DMPO, an ESR spectrum resulting from the trapping 
of two different radical intermediates is observed (Fig.
1A). The major, six-line spin adduct (Fig. 1A, closed 
circles) has hyperfine splitting constants (hfsc) of ajj =
1.63 mT and ajj = 2.34 mT, consistent with the adduct being 
a carbon-centered radical (9). The four-line signal (Fig. 
1A, open circles) has hfsc of ajj = 1.52 mT and ajj = 1.64 
mT, consistent with a thiyl radical spin adduct (10).
There has been a report (11) that the tert-butoxvl spin 
adduct has similar hfsc; however, when tert-butoxvl 
radicals are generated by either photochemical or iron(II)- 
induced decomposition of tert-butyl hydroperoxide in 
aqueous buffer with 50 mM DMPO, we observe only the six- 
line signal attributed to the carbon-centered radical 
adduct, presumably due to methyl radicals formed by the 
rapid decomposition of tert-butoxvl radicals. In fact, 
tert-butoxvl radicals decompose to form methyl radicals and 
acetone much faster in water than in organic solvents (12). 
All of these data taken together clearly suggest that the 
carbon-centered spin adduct observed in our mitochondrial 
system is the methyl radical. The same two signals shown 
in Fig. 1A also are observed after the mitochondria are
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Figure 1: The ESR spectrum of radicals generated by the addition of
tert-butyl hydroperoxide (TBHP) to rat liver mitochondria in the 
presence of two different spin traps. (A) Incubation containing 8.4 
mg mitochondrial protein, 1.4 mM TBHP, and 49 kiM DMPO in HEPES 
buffer, pH 7.4. (B) Same as in A except 20 ul Triton X-100 was used
to solubilize the mitochondria. (C) Same as in A except that 55 mM 
MNP was used as the trap. (D) Gaussian simulation of the methyl-MNP 
adduct using experimentally measured hfscs. (E) Gaussian simulation 
of the tert-butyl nitroxide signal using experimentally measured 
hfscs. All ESR measurements were carried out on an IBM Instruments 
model ER200-SRC spectrophotometer equipped with an Aspect 2000 data 
system. The following instrument conditions were used: microwave 
power, 20 mW; modulation amplitude, 0.32 X 10'^ T; receiver gain, 4 
X 10^; time constant, 100 ms; sweep width, 90 X lO'^ 1 T; sweep time, 
100 s ; number of scans, 10.
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solubilized in Triton X-100 (Fig IB), so an intact 
mitochondrial membrane is not required. Weak signals due 
to the DMPO-superoxide spin adduct (Fig. IB, crosses) and 
the ascorbyl radical (Fig. IB, closed squares) also are 
observed with Triton X-100.
To further probe the identity of the carbon-centered 
radical, the spin trapping experiment was repeated in the 
presence of the spin trap MNP, and a twelve-line signal (a^
= 1.73 mT and an = 1.43 mT) characteristic of the MNP- 
methyl radical adduct was observed (Fig. 1C, closed 
triangles) (9). Three of the lines in the spectrum (Fig.
1C, open squares) are due to di-tert-butvl nitroxide, the 
photolytic decomposition product of MNP. A Gaussian 
simulation of the MNP-methyl radical adduct (Fig. ID) is 
not completely consistent with the ratio of the peak 
intensities in the experimental spectrum, suggesting the 
presence of an overlapping four-line signal with hfsc of a^
= 1.44 mT and = 1.44 mT; the Gaussian simulation of this 
adduct is shown in Fig. IE. On the basis of the hfsc, we 
identify this signal as hvdro-tert-butyl nitroxide (13).
This species probably results from a one-electron reduction 
of MNP, followed by protonation, indicating the presence of 
a one-electron reducing agent.
The spin trapping experiments were also carried out 
with TBHP added to both respiring, Ca2+-deficient 
mitochondria and respiring, Ca2+-loaded mitochondria.
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Neither respiration nor calcium loading causes significant 
changes in the signal observed with non-respiring, Ca2+- 
deficient mitochondria (results not shown), implying that 
radicals arise from a reaction pathway that is independent 
of the mechanism(s) by which TBHP induces Ca2+ release from 
Ca2+-loaded mitochondria (4,5).
Effect of Additives on TBHP-Induced Radical Production 
in Non-Resoirinq Mitochondria. The effect of a number of 
additives was investigated to elucidate the mechanism of 
the radical-generating reaction. The presence of a thiyl 
radical signal implies that a sulfur-containing compound is 
involved in the radical-generating reaction. N- 
Ethylmaleimide (NEM), which reacts with reduced sulfhydryl 
groups (14,15), causes a significant reduction in the 
intensity of the DMPO-methyl radical adduct signal (Table 
I) and induces the formation of an ascorbyl radical signal 
(Fig. 2). Interestingly, an ascorbyl signal was also 
observed when linoleic acid hydroperoxide was added to rat 
liver homogenate (16).
Many hydroperoxide reactions are metal-mediated 
(17,18). Consistent with this observation, EDTA partially 
diminishes the intensity of the DMPO-methyl radical adduct 
signal (Table I).
The role of oxygen in the reaction between TBHP and 
mitochondria was examined by incubating the reaction 
mixture both aerobically and anaerobically in the presence
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Table I: Effect of additives on TBKP-induced radical 
production in mitochondria - relative ESR signal intensities
Additive3 Relative Signal Intensity^
4.9 mM N-ethylmaleimide 0.4
2.1 mM EDTA 0.3
none (aerobic incubation) 0.4
none (anaerobic incubation) 0.8
a) All reaction mixtures contained 11 mg mitochondrial protein, 1.4 
mM TBHP, and 48 mM DMPO in HEPES buffer, pH 7.4.
b) The signal observed with TBHP alone (no additives, no incubation) 
was used as a reference. The peak of the first line of the methyl- 
DMPO adduct signal was used for peak height measurements.
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Figure 2: ESR spectrum showing the effect of sulfhydryl group
depletion on the reaction between tert-butvl hydroperoxide (TBHP) 
and rat liver mitochondria. The reaction mixture contained 11 mg 
mitochondrial protein, 4.9 mM N-ethylmaleimide, 1.4 mM TBHP, and 48 
mM DMPO in HEPES buffer, pH 7.4.
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of DMPO. After aerobic incubation, the DMPO-methyl radical 
adduct signal was significantly diminished (Table I), 
indicating that oxygen inhibits radical production.
Anaerobic incubation did not have a significant effect on 
radical production (Table I), although this lack of effect 
may be due to an inability to completely remove O2 from the 
mitochondria.
These data suggest that TBHP induces radical 
production in mitochondria through a metal-mediated 
reaction between an endogenous reductant (either ascorbate 
or glutathione) and the hydroperoxide. These radicals 
could initiate lipid peroxidation in mitochondrial 
membranes. We are currently investigating the fate and 
reactions of radicals from hydroperoxide decomposition, 
both in mitochondria and chemical model systems and are 
probing the role of metal-containing enzymes (such as P450) 
in the reaction.
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ABSTRACT
When isolated rat liver mitochondria are treated with 
tert-butvl hydroperoxide (TBHP) in the presence of the spin 
trap 5,5-dimethyl-l-pyrroline-N-oxide (DMPO), ESR signals 
attributable to spin adducts are observed resulting from 
the trapping of methyl, tert-butyoxyl and tert- 
butylperoxyl radicals. The addition of respiratory 
substrate results in a 3- to 7.5-fold increase in the 
signal intensity of the methyl-DMPO adduct, no change in 
the signal intensity of the tert-butoxyl-DMPO adduct and 
complete loss of the tert-butylperoxyl-DMPO adduct. The 
magnitude of increase of methyl radical production in the 
presence of respiratory substrate is related to the 
respiratory control ratio (RCR) of the mitochondrial 
preparation. In the presence of antimycin A, which blocks 
electron flow between cytochromes b and cj_, no stimulation 
of methyl radical production is observed with respiratory 
substrate. This indicates that electrons are being 
intercepted by TBHP from a cytochrome component on the 
oxidase side of cytochrome b. Reduction of TBHP results in 
the formation of tert-butoxyl radicals, which subsequently 
undergo beta-scission to form methyl radicals. Stimulation 
of methyl radical production by the addition of respiratory 
substrate is observed in cytochrome c-depleted 
mitochondria, indicating that TBHP is reduced by cytochrome 
ci- Calcium-loading of the mitochondria has no significant
effect on hydroperoxide-induced radical production. The 
addition of metal chelators has no significant effect on 
TBHP-induced radical production and radical production is 
inhibited by sodium cyanide in non-respiring mitochondria, 
suggesting that TBHP interacts with a tightly-ligated 
metal. Radical production is-also observed when either 
cumene hydroperoxide or linoleic acid hydroperoxide is 
added to the mitochondria in the presence of spin trap.
ABBREVIATIONS
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BHB, beta-hydroxy butyrate; BSA, bovine serum albumin;
CCCP, carbonyl cyanide m-chlorophenylhydrazone; CHP, cumene 
hydroperoxide; ESR, electron-spin resonance; DMPO, 5,5- 
dimethyl-l-pyrroline-N-oxide; DTNB, 5,5'-dithiobis(2- 
nitrobenzoic acid); DMPOX, 5,5-dimethyl-1-pyrrolidone-2- 
oxyl radical; EDTA, ethylenediamine tetraacetic acid; EGTA, 
[ethylenebis-(oxyethylenenitrilo) ] tetraacetic acid; GSH, 
reduced glutathione; HEPES, 4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid; LHP, linoleic acid 
hydroperoxide; MNP, 2-methyl-2-nitrosopropane; MSA, 
mercaptosuccinic acid; NEM, N-ethylmaleimide; PBN, N-tert- 
butyl-alpha-phenylnitrone; SOD, superoxide dismutase; TBA, 
2-thiobarbituric acid; TBHP, tert-butyl hydroperoxide; TCA, 
trichloroacetic acid.
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INTRODUCTION
Skin carcinogenesis can be divided into initiation, 
promotion and progression stages. Tumor initiation is an 
irreversible step that arises from the interaction of a 
carcinogen with DNA resulting in gene alteration (1).
During the promotion stage, the altered genetic material of 
the initiated cell becomes expressed through selection and 
clonal expansion (2). The result of initiation followed by 
promotion is commonly the formation of a high yield of 
benign tumors. The progression of tumors from a benign to 
malignant neoplasm occurs in the final stage of 
carcinogenesis; this transformation is proposed to involve 
further genetic changes caused by mutagenic agents (3,4). 
This model of carcinogenesis has been shown to exist in a 
number of systems including the liver (5).
Several peroxidic compounds are active as tumor 
promoters; benzoyl peroxide (BPO), cumene hydroperoxide 
(CHP), decanoyl peroxide, dicumyl peroxide, and lauroyl 
peroxide are strong promoters while tert-butyl 
hydroperoxide (TBHP), hydrogen peroxide, and methyl ethyl 
ketone peroxide are less active (6-10). Although free 
radicals have been implicated in tumor promotion (11,12), 
there is little direct evidence that the tumor promoting 
activity of peroxidic compounds is due to their ability to 
induce radical production.
A number of tumor promotors have been shown to induce 
epidermal hyperplasia and the formation of dark basal 
keratinocytes in skin; the number of these induced cells 
correlates well with the tumor-promoting activity of 
several promoters (13,14). Although TBHP and cumene 
hydroperoxide have been shown by ESR spin-trapping studies 
to induce radical production in keratinocytes (15), the 
significance of these radicals in the process of tumor 
promotion is unknown. The radical process of lipid 
peroxidation has been shown to be inducible in 
keratinocytes but is unrelated to cell damage (16)? BPO is 
cytotoxic to these cells but does not induce lipid 
peroxidation (16). The cytotoxicity of BPO may be 
explained by the fact that it inhibits mitochondrial 
electron- and energy-transfer and induces rapid, large- 
amplitude swelling of mitochondria (17). Thus, the 
mitochondrion may be an important organelle in the 
interaction between peroxide tumor promotors 
and whole cells.
In cancer cells, mitochondrial function is reported to 
be impaired (18); these impairments include changes in 
ultrastructure, defective energy-linked functions, and 
altered Ca2+ transport. Prooxidant promoters, including 
organic peroxides, have been shown to cause similar changes 
in mitochondrial function. Although peroxidic tumor 
promoters are known to impair normal mitochondrial
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function, it remains to be established whether such 
impairment is involved in the tumor promotion process.
Peroxide-induced mitochondrial damage occurs by both 
radical and non-radical pathways. CHP has been shown to 
yield radicals that initiate mitochondrial lipid 
peroxidation by a mechanism that involves mitochondrial 
cytochrome P-450 (19). In contrast, BPO alters 
mitochondrial function by an apparently non-radical process 
(17). The interaction of TBHP with mitochondria has been 
shown to occur by both radical and non-radical pathways; 
for example, TBHP initiates mitochondrial swelling via a 
non-radical process that is dependent on Ca2+ cycling (20- 
22). However, we previously reported that TBHP forms free 
radicals in mitochondria as shown by ESR spin trapping 
(23) .
Herein, we report a study of the mechanism of 
hydroperoxide-induced radical production in rat liver 
mitochondria using the ESR spin trapping method.
MATERIALS AND METHODS
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Chemicals. tert-Butyl hydroperoxide (TBHP), Cumene 
hydroperoxide (CHP), linoleic acid and 2-methyl-2- 
nitrosopropane (MNP) were obtained from Aldrich. N-tert- 
butyl-alpha-phenylnitrone (PBN) was from Kodak. Bovine 
serum albumin (BSA), catalase, glutathione peroxidase, 
soybean lipoxygenase (type 1-S) and superoxide dismutase 
were purchased from Sigma. Desferal (desferrioxamine 
mesylate) was provided by Ciba-Geigy. 5,5-Dimethyl-l- 
pyrroline N-oxide (DMPO) was obtained from Sigma and 
purified by diluting with distilled, deionized water, 
stirring with decoloring carbon for 5 minutes and then 
filtering. Linoleic acid hydroperoxide (LHP) was prepared 
and isolated according to the method of Gardner (24). All 
other chemicals were commercial samples of high purity and 
were used as supplied.
Preparation of Rat Liver Mitochondria. Adult male 
Sprague-Dawley rats (175-275 g) were fasted overnight and 
sacrificed by decapitation. Liver mitochondria were 
isolated by differential centrifugation (25) using 210 mM 
mannitol, 70 mM sucrose, 5 mM HEPES (pH 7.4), 1 mM EDTA, 1 
mM EGTA, and 0.15% bovine serum albumin (BSA).
Mitochondria were washed in the same medium without EDTA, 
EGTA, and BSA. Mitochondria prepared for the TBA test were 
washed in 150 mM NaCl. Cytochrome c-depleted mitochondria 
were prepared by treatment with hypotonic medium followed
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by washing with salt solution according to the method of 
Jacobs and Sanadi (26).
Determination of Protein Concentration. The protein 
concentration of the mitochondrial suspensions were 
determined by the method of Bradford (27) using BSA as a 
standard.
ESR Spin Trapping in Mitochondria. Rat liver 
mitochondria (5.0 mg mitochondrial protein) were incubated 
at room temperature for one minute with either DMPO (50 mM, 
final concentration), MNP (55 mM, final concentration) or 
PBN (50 mM, final concentration) in MSH buffer (210 mM 
mannitol, 70 mM sucrose, 5 mM HEPES, pH 7.4) prior to the 
addition of the hydroperoxide (final concentrations shown 
in figure legends). After a 1 min incubation in the 
presence of the oxidant, the suspension was placed in a 17 
mm flat cell and degassed by vacuum. The flat cell was 
then mounted in the T M n o  wide-bore cavity for ESR 
measurements at X-band frequency. All ESR measurements 
were initiated 3 min after the addition of the oxidant. In 
experiments with respiring mitochondria, either sodium 
succinate (10 mM, final concentration) or beta- 
hydroxybutyrate (10 mM, final concentration) was added to 
the mitochondria 1 min prior to the addition of 
hydroperoxide. In some experiments, the mitochondria were 
solubilized in Triton X-100 (1.3% v/v, final concentration) 
prior to the addition of DMPO. When additives were used,
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these compounds were added to the reaction mixture prior to 
the addition of the oxidant (final concentrations shown in 
Tables I and II). Anaerobic and aerobic incubations were 
performed by purging the mitochondria with either nit-rogen 
or oxygen for 5 min prior to the addition of TBHP.
Measurement of Lipid Peroxidation by the TBA Test. 
Peroxidation of mitochondrial membrane lipids was assessed 
by the spectrophotometric determination of TBA-reactive 
products according to the procedure described by Aust (28). 
Coupled rat liver mitochondria (6.0 mg protein) were added 
to 6.0 ml (final volume) of medium saturated with air at 
25°C and containing 150 mM NaCl at a final pH of 7.4. A 
1.0 ml aliquot was removed and added to 2.0 ml of stock 
TBA-TCA—HC1 reagent (15% w/v TCA, 0.375% TBA, 0.25 N HCl). 
Either mercaptosuccinic acid (MSA), sodium succinate, TBHP 
or a combination of these compounds were added to the 
remaining mitochondria (final concentrations given in 
Figure 8). Aliquots (1.0 ml) were removed at 30, 60, 90, 
and 120 min following the addition of the initiator and 
added to stock TBA-TCA-HC1 reagent. The samples were 
placed in a boiling water bath for 15 min, cooled and 
centrifuged to remove the precipitate formed during 
boiling. The absorbance of the samples was measured at 532 
nm on a Hewlett Packard UV-visible spectrophotometer 
against a blank that contained all the reagents but no 
mitochondria.
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RESULTS AND DISCUSSION
Identification of Radicals Produced bv Hydroperoxides 
in Mitochondria. When non-respiring, Ca2+-deficient rat 
liver mitochondria are treated with TBHP in the presence of 
the spin trap DMPO, an ESR spectrum resulting from the 
trapping of three different radical intermediates is 
observed (Fig. 1A). Gaussian simulations of the individual 
adducts are shown in Fig. 1, C-E. The hyperfine splitting 
constants (hfsc) of the major, six-line signal (a*j = 1.66 
mT, an = 2.38 mT) (Fig. 1C) identify it as a carbon- 
centered radical adduct (29) . The four-line signal (a*j =
1.49 mT^ an = 1.67 mT) (Fig. ID) could be either a thiyl 
radical spin adduct (30) or a tert-butoxyl spin adduct 
(31). The twelve-line signal (ajj = 1.48 mT, ajj = 1.09 mT, 
an = 0.15 mT) (Fig. IE) is identified as a peroxyl spin 
adduct (32), although the possibility of trapping 
superoxide to form a hydroperoxyl adduct must be 
considered. A simulation of the combination of these 
adducts (Fig. IB) compares well to the experimental 
spectrum (Fig. 1A). When mitochondria are heat-denatured 
prior to the addition of TBHP, a significant reduction in 
radical production is observed (Fig. IF), indicating that 
TBHP reacts with a heat-labile component of mitochondria.
No radical adducts are observed in the absence of the 
hydroperoxide (Fig. 1G).
125
A
m
B
IT
D
F 1
r 5.0 mT
Figure 1: The ESR spectrum of radicals generated by the addition of
tert-butyl hydroperoxide (TBHP) to rat liver mitochondria in the 
presence of DMPO. (A) Incubation containing 5.0 mg mitochondrial 
protein, 10 mM TBHP, and 50 mM DMPO in MSH buffer, pH 7.4, (B)
Gaussian simulation of spectra C-E. (C) Gaussian simulation of 
DMPO-carbon-centered adduct. (D) Gaussian simulation of DMPO-tert- 
butoxyl adduct. (E) Gaussian simulation of DMPO-tert-butylperoxyl 
adduct. (F) Same as in A except mitochondria were heat-denatured 
prior to addition of DMPO and TBHP. (G) Same as in A except no TBHP 
was added. ESR measurements were carried out on an IBM Instruments 
model ER100D spectrophotometer equipped with an Aspect 2000 data 
system. The following instrument conditions were used: microwave 
power, 20 mW; modulation amplitude, 0.32 X 10'^ T; receiver gain, 4 
X 10^; time constant, 100 ms; sweep width, 90 X 10"^ T; sweep time, 
100 s; numbdr of scans, 10.
The identity of the carbon-centered radical has been 
probed by repeating the spin trapping experiment in the 
presence of the spin trap MNP. A spectrum consisting of 
three spin adducts is observed (Fig. 2A). Gaussian 
simulations of the individual adducts are shown in Fig. 2, 
C-E. The twelve-line signal (Fig. 2C) has hfsc 
characteristic of the MNP-methyl radical adduct (ajj = 1.73 
mT, an = 1.43 mT) (29). The simulation of the MNP-methyl 
radical adduct (Fig. 2C) is not completely consistent with 
the ratio of the peak intensities in the experimental 
spectrum, suggesting the presence of an overlapping four- 
line signal (aN = 1.44 mT, ajj = 1.44 mT) (Fig. 2D). On the 
basis of these hfsc, we identify this signal as due to 
hydro-tert-butyl nitroxide (33). Three of the lines in the 
spectrum are due to di-tert-butyl nitroxide (a*j = 17.1 mT), 
the photolytic decomposition product of MNP (Fig. 2E) (34).
When these simulations are combined, the resulting spectrum 
(Fig. 2B) compares well to the experimental spectrum (Fig. 
2A) .
The identity of the four-line DMPO spin adduct (Fig. 
1A) has been probed by generating bona-fide thiyl-DMPO and 
tert-butoxyl-DMPO adducts. The thiyl-DMPO adduct (aN =
1.54 mT, ay = 1.62 mT) was generated by photolysis of 10 mM 
oxidized glutathione (GSSG) in the presence of 50 mM DMPO. 
The tert-butoxyl-DMPO adduct (a^ = 1.50 mT, an = 1.68 mT) 
was generated by reacting 0.1 mM FeS04 with 1.5 mM TBHP in
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Figure 2 : The ESR spectrum of radicals generated by the addition of 
tert-butvl hydroperoxide (TBHP) to rat liver mitochondria in the 
presence of MNP. (A) Incubation containing 8.4 mg mitochondrial 
protein, 1.4 mM TBHP, and 55 mM MNP in MSH buffer, pH 7.4. (B)
Gaussian simulation of spectra C-E. (C) Gaussian simulation of the 
methyl-MNP adduct. (D) Gaussian simulation of the hydro-tert-butyl 
nitroxide signal. (E) Gaussian simulation of the di-tert-butvl
nitroxide signal. Instrument conditions same as in Figure 1 except 
ESR measurements were carried out on an IBM Instruments model ER200- 
SRC spectrophotometer.
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the presence of 50 mM DMPO. On the basis of these hfsc 
values, we identify the four-line adduct (ajj = 1.49 mT, ay 
= 1.67 mT) produced when mitochondria are treated with TBHP 
in the presence of DMPO as the tert-butoxyl-DMPO adduct.
Superoxide dismutase (SOD) is commonly used to 
distinguish between trapping of superoxide (as the 
hydroperoxyl adduct) and peroxyl radicals (35). Due to its 
size, SOD would not be expected to cross an intact 
mitochondrial membrane. To circumvent this problem, we 
have used detergent-solubilized mitochondria. The same 
signals shown in Fig. 1A also are observed after the 
mitochondria are solubilized in Triton X-100 and then 
treated with TBHP in the presence of DMPO; therefore, an 
intact mitochondrial membrane is not required to observe 
hydroperoxide-induced radical production. We have shown 
that SOD is active in the presence of Triton X-100 by 
adding it to a detergent-solubilized xanthine/xanthine 
oxidase system in the presence of DMPO; in the absence of 
SOD, a twelve-line superoxide adduct is observed while no 
signal is observed in the presence of SOD. When Triton X- 
solubilized mitochondria are treated with TBHP in the 
presence of SOD and DMPO, no change is observed in the 
intensity of the twelve-line adduct, suggesting that this 
adduct is the tert-butylperoxyl-DMPO adduct and not the 
hydroperoxyl-DMPO adduct.
When cumene hydroperoxide is added to non-respiring, 
Ca2+-deficient rat liver mitochondria in the presence of 
DMPO, three radical intermediates are trapped (Fig. 3A).
In this case, the twelve-line signal (a^ = 1.47 mT, aj* = 
1.08 mT, an = 0.15 mT) is dominant. The intensity of the 
six-line signal (a^ = 1.66 mT, an = 2.38 mT) is 
significantly reduced while the four-line signal (intensity 
too low to measure hfscs) is almost non-existent. On the 
basis of the similarity of these signals to those observed 
in the TBHP system, we assign the twelve-line signal to a 
peroxyl-DMPO adduct and the six-line signal to the methyl- 
DMPO adduct. Gaussian simulations of these adducts are 
shown in Fig. 3, C-E. The simulation of the combination of 
these adducts (Fig. 3B) compares well with the experimental 
spectrum (Fig. 3A).
When linoleic acid hydroperoxide (LHP) is added to 
mitochondria in the presence of DMPO, only a very weak 6- 
line ESR signal is observed (Fig. 4A). This result may be 
due to the inability of LHP to generate radicals in this 
mitochondrial system or to the fact that DMPO is a 
hydrophilic spin trap. In the latter case, radicals 
generated by the decomposition of L00H in a lipophilic 
environment may not be trapped by DMPO. To probe this 
possibility, mitochondria were treated with L00H in the 
presence of PBN, a lipophilic spin trap; a spectrum 
resulting from the trapping of a carbon-centered radical
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Figure 3: The ESR spectrum of radicals generated by the addition of 
cumene hydroperoxide (CHP) to rat liver mitochondria in the presence 
of DMPO. (A) Incubation containing 5.0 mg mitochondrial protein, 10 
mM CHP, and 50 mM DMPO in MSH buffer, pH 7.4. (B) Gaussian
simulation of spectra C-E. (C) Gaussian simulation of DMPO-carbon- 
centered adduct. (D) Gaussian simulation of DMPO-cumyloxyl adduct. 
(E) Gaussian simulation of DMPO-cumylperoxyl adduct. Instrument 
conditions same as in Figure 1.
131
C
D --- * - * -
5.0mT
K :--- H
Figure 4: The ESR spectrum of radicals generated by the addition of 
linoleic acid hydroperoxide (LHP) to rat liver mitochondria in the 
presence of either DMPO or PBN. (A) Incubation containing 5.0 mg 
mitochondrial protein, 10 mM LHP, and 50 mM DMPO in MSH buffer, pH 
7.4. (B) Same as in A except 50 mM PBN was used instead of DMPO.
(C) Stick simulation of carbon-centered-PBN adduct in A. (D) Stick 
simulation of oxygen-centered-PBN adduct in A. Instrument 
conditions same as in Figure 1.
(ajj = 1.63 mT, an = 0.28 mT) and an oxygen-centered radical
(ajj = 1.46 mT, ay = 0.16 mT) is observed (Fig. 4B) . Stick
simulations of these adducts are shown in Fig. 4C and 4D.
Our measured hfsc values for these adducts are consistent
with literature values for PBN adducts of L-C* (3 6) and LO* 
(37) respectively. These results indicate that LHP does 
induce radical production in mitochondria and suggest that 
generation of radicals occurs in a non-aqueous environment. 
No increase in DMPO spin adduct formation is observed when 
Triton X-solubilized mitochondria are treated with LHP 
compared to that seen in unsolubilized mitochondria (Fig. 
4A). Thus, the inability to trap radicals in LHP-induced 
radicals in mitochondria with DMPO is a function of the 
spin trap (i.e., rate of trapping and/or stability of 
adducts) and not the environment of radical production.
PBN spin adducts are also observed when mitochondria 
are treated with either TBHP (Fig. 5A) or CHP (Fig. 5D) in 
the presence of this spin trap. In each case, a spectrum 
resulting from the trapping of two radical species is 
observed. TBHP (Fig. 5A) induces the production of both a 
carbon-centered radical (ajj = 1.67 mT, ay - 0.35 mT) and an 
oxygen-centered radical (a^ = 1.53 mT, an = 0.35 mT).
Stick simulations of the individual adducts are shown in 
Fig. 5B and 5C. These hfsc values are consistent with 
literature values (38) for the PBN-methyl radical adduct 
(a^ = 1.66 mT, aji = 0.36 mT) and PBN-tert-butoxyl radical
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Figure 5: The ESR spectrum of radicals generated by the addition of 
either tert-butyl hydroperoxide (TBHP) or cumene hydroperoxide (CHP) 
to rat liver mitochondria in the presence of PBN. (A) Incubation 
containing 5.0 mg mitochondrial protein, 10 mM TBHP, and 50 mM PBN 
in MSH buffer, pH 7.4. (B) Stick simulation of carbon-centered-PBN
adduct in A. (C) Stick simulation of oxygen-centered-PBN adduct in 
A. (D) Same as in A but 10 mM CHP added instead of TBHP. (E) Stick 
simulation of carbon-centered-PBN adduct in D. (F) Stick simulation 
of oxygen-centered-PBN adduct in D. Instrument conditions same as 
in Figure 1.
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adduct (a^ = 1.53 mT, ajj = 0.33 mT) . CHP (Fig. 5D) also 
induces the production of both a carbon-centered radical 
(ay = 1.67 mT, aj{ = 0.37 mT) and an oxygen-centered radical 
(ajj = 1.53 mT, aj^  = 0.35 mT) . Stick simulations of the 
individual adducts are shown in Fig. 5E and 5F. The 
carbon-centered adduct can likewise be identified as the 
PBN-methyl radical adduct. The oxygen-centered adduct may 
be due to trapping of either cumyloxyl or cumylperoxyl 
radicals. Since the peroxyl-DMPO adduct is the major 
signal when CHP is added to mitochondria in the presence of 
DMPO (Fig. 3A) , the oxygen-centered adduct in Fig. 5D is 
probably also a peroxyl adduct, although it is difficult to 
distinguish between alkoxyl and peroxyl adducts with PBN.
Effect of Additives on TBHP-Induced Radical Production 
in Respiring Mitochondria. When sodium succinate, a 
FADH2-linked substrate, is added to mitochondria prior to 
the addition of TBHP, a significant enhancement in the 
intensity of the methyl-DMPO adduct is observed (Fig. 6).
A greater stimulation in radical production is observed as 
the respiratory control ratio (RCR) increases. For 
example, a mitochondrial preparation with a RCR of 2.7 
yielded a 2.9-fold stimulation of TBHP-induced radical 
production in the presence of substrate whereas a 
mitochondrial preparation with a RCR of 5.2 resulted in a 
7.6-fold stimulation. In uncoupled mitochondria, the rate 
of state 4 respiration is increased compared to tightly
11
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Figure 6: The effect of respiratory substrate on tert-butyl 
hydroperoxide (TBHP)-induced radical production in rat liver 
mitochondria. (A) Incubation containing 5.0 mg mitochondrial 
protein, 1.5 mM TBHP, and 50 mM DMPO in MSH buffer, pH 7.4. (B)
same as in A but 10 mM sodium succinate added prior to TBHP. 
Instrument conditions same as in Figure 1.
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coupled preparations. When mitochondria are treated with 
the uncoupling agent carbonyl cyanide m- 
chlorophenylhydrazone (CCCP) prior to the addition of 
sodium succinate and TBHP, a 40% inhibition of substrate- 
enhanced, TBHP-induced radical production is observed 
(Table I). This result suggests a lower electron acceptor 
efficiency of TBHP under conditions of an increased rate of 
electron transport.
When beta-hydroxybutyrate (BHB), a NADH-linked 
substrate, is added to mitochondria prior to TBHP, a 5.1- 
fold increase in radical production is observed when a 
mitochondrial preparation with an RCR of 4.1 is used. The 
fact that both NADH- and FADH2~linked substrates stimulate 
TBHP-induced radical production in mitochondria suggests 
either that TBHP interacts at a site other than NADH- 
oxidase and succinoxidase or that TBHP interacts with both 
of these sites. The ability of respiratory substrate to 
enhance TBHP-induced radical production in mitochondria was 
studied in the presence of inhibitors of mitochondrial 
electron transport to better identify a locus of 
interaction of TBHP (Table I). Rotenone, a NADH-oxidase 
inhibitor (Fig. 7), inhibited radical production when added 
to mitochondria prior to BHB. The intensity of methyl-DMPO 
adduct measured in the presence of rotenone is equal to 
that seen in the absence of respiratory substrate, 
suggesting that TBHP does not accept electrons from NADH-
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Table X: Effects of additives on TBHP-induced 
radical production in respiring mitochondria - 
relative ESR signal intensities.
Additive3, Relative Signal Intensity13
3.6 uM CCCP 0.6
4.9 uM rotenone0 0.2
0.65 uM antimycin A 0.2
0.1 mM desferal 0.9
0.23 mM CaCl2 1.2
None (anaerobic incubation)^ 1.1
a) All reaction mixtures contained 5 mg mitochondrial protein,
10 mM succinate, 4.9 uM rotenone, 1.5 mM TBHP, and 50 mM DMPO 
in MSH buffer, pH 7.4 (except where noted).
b) The intensity of the signal in the presence of the additive was 
divided by the intensity of the signal with respiratory substrate 
and TBHP alone (no additives, no incubation). The low-field peak 
of the methyl-DMPO adduct was used for peak height measurements. 
All experiments were performed in duplicate.
c) 10 mM b-OH butyrate was used as the respiratory substrate 
instead of succinate. In the reference experiments using this 
substrate, no rotenone was added.
d) Mitochondria were purged with nitrogen for 5 min prior to the 
addition of TBHP.
NAD-Linked 
Substrotes 
(e.g./3-OH Butyrote)
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Figure 4: The mitochondrial electron transport chain.
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oxidase. When antimycin A, an inhibitor of coenzyme Q- 
cytochrome c reductase (Fig* 7 )t is added to mitochondria 
prior to sodium succinate, inhibition of radical production 
is observed. This result suggests that TBHP does not 
accept electrons from a chain component on the substrate 
side of cytochrome c^. Thus, on the basis of these 
results, TBHP must interact with either cytochrome c^ or a 
cytochrome on the oxidase side of this electron carrier.
The addition of desferrioxamine to mitochondria 
prior to respiratory substrate results in no significant 
inhibition of TBHP-induced radical production (Table I). 
Although desferrioxamine is an efficient ferric iron 
chelator, it does not remove iron from heme groups (32).
This suggests either that the metal center involved in the 
reaction with TBHP is tightly bound to ligands (e.g., heme 
iron) or that the metal is not iron (which is a possibility 
since there is a copper center in cytochrome oxidase).
TBHP has been shown to interact with ferricytochrome c 
in submitochondrial particles (39) and in an isolated, 
purified state (40). It has been proposed that the 
hydroperoxide binds to the sixth ligand position of the 
iron (41,42) and is then cleaved via a cytochrome c- 
catalyzed homolytic rupture of the oxygen-oxygen bond of 
the hydroperoxide (43,44). Davies (32) has observed that 
interaction of TBHP with ferricytochrome c in the presence 
of DMPO results in the production of alkoxyl-, peroxyl- and
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methyl-DMPO adducts as well as 5,5-dimethyl-l-pyrrolidone- 
2-oxyl radical (DMPOX). To establish whether TBHP 
interacts specifically with either cytochrome ci or 
cytochrome c, mitochondria have been depleted of cytochrome 
c and then treated with sodium succinate and TBHP in the 
presence of DMPO. Enhancement of TBHP-induced radical 
production by respiratory substrate is observed in this 
system, indicating that at least the majority of electron 
interception by TBHP must take place at cytochrome ci.
TBHP is known to induce calcium cycling in 
mitochondria by a mechanism that is dependent on the 
metabolism of the hydroperoxide by mitochondrial 
glutathione peroxidase (20-23). We have examined TBHP- 
induced radical production in calcium-loaded, respiring 
mitochondria to determine whether calcium cycling is 
important in the mechanism of radical production.
Calcium loading did not cause any significant change in 
radical production (Table I), implying that radicals arise 
from a reaction pathway that is independent of the 
mechanism(s) by which TBHP induces Ca2+ release from Ca2+- 
loaded mitochondria (20-23).
The effect of oxygen on TBHP-induced radical 
production has been investigated by purging mitochondria 
with N2 for 5 min prior to the addition of respiratory 
substrate and TBHP. Anaerobic incubation has no 
significant effect on methyl radical production (Table I).
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Thus, oxygen does not appear to limit electron supply to 
TBHP.
Effect of Additives on TBHP-induced Radical Production 
in Non-Respirina Mitochondria. Enhancement of methyl 
radical production upon the addition of either ascorbic 
acid or GSH to mitochondria (Table IX) may be due to 
reduction of endogenous iron by these compounds followed by 
electron transfer to TBHP. It is not surprising that no 
alkoxyl-DMPO or peroxyl-DMPO adducts are observed when 
ascorbic acid is present (data not shown) since this 
compound is a good scavenger of oxygen-centered radicals 
(45). It is also believed to enhance the radical- 
scavenging ability of vitamin E by reducing oxidized alpha- 
tocopherol (46). Thus, ascorbic acid may act as both a 
stimulator and inhibitor of radical production in the 
mitochondria/TBHP system.
Because many hydroperoxide reactions are metal- 
mediated (47,48), the effect of metal chelators on TBHP- 
induced radical production in mitochondria was studied.
The 3 0% inhibition of radical production by desferrioxamine 
(Table II) can be rationalized by the ability of this 
compound to scavenge oxygen-centered radicals. The 
inhibition of lipid peroxidation by desferrioxamine has 
been attributed to the ability of this compound to act as 
an electron or hydrogen atom donor rather than by chelation 
of iron (49). EDTA only reduces TBHP-induced radical
Table II: Effects of additives on TBHP-induced 
radical production in non-respiring mitochondria 
relative ESR signal intensities.
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Additivea Relative Signal Intensity*1
0.5 mM ascorbic acid 1.5
0.5 mM GSH 1.7
0.1 mM desferal 0.7
2.0 mM EDTA 0.8
9.6 mM sodium cyanide 0.3
0.2 mM FeCl3 0.9
0.2 mM CuCl2 0.9
4.9 mM NEM 0.5
5.0 mM DTNB 1.0
none (anaerobic incubation)c 1.7
none (aerobic incubation)d 1.0
carbon monoxidee 2.0
1 unit/ml GSH-peroxidase + 3.3 mM GSH*- 0.3
1.0 mg/ml BSA^ 0.6
1.0 mg/ml catalase^ 0.6
50 ug/ml superoxide dismutase^ 1.1
a) All reaction mixtures contained 5 mg mitochondrial protein,
1.5 mM TBHP, and 50 mM DMPO in MSH buffer, pH 7.4.
b) The intensity of the signal in the presence of the additive was 
divided by the intensity of the signal with TBHP alone (no 
additives, no incubation). The low-field peak of the methyl-DMPO 
adduct was used for peak height measurements. All experiments 
were performed in duplicate.
c) Mitochondria were purged with nitrogen for 5 min prior to the 
addition of TBHP.
d) Mitochondria were purged with oxygen for 5 min prior to the 
addition of TBHP.
e) Mitochondria were purged with carbon monoxide for 30 sec 
prior to the addition of TBHP.
f) Mitochondria were solubilized with Triton X-100 (1.3 % v/v) 
prior to addition of protein and TBHP.
production by 20% (Table II). The fact that these 
chelators are unable to completely inhibit radical 
production suggests either that, as in the respiring 
system, the metal center which interacts with TBHP is 
tightly bound to ligands or that the reaction is not metal- 
mediated. To further probe these possibilities, sodium 
cyanide, a compound known to react with heme iron (50), was 
added to mitochondria prior to TBHP. significant 
inhibition of radical production by sodium cyanide (Table 
II) suggests that this compound interferes with the 
reaction between TBHP and a metal center either by altering 
the redox potential of the liganded metal (51,52) such that 
it inhibits charge transfer between the metal and peroxide 
or by inhibiting the binding of TBHP to the metal center 
(40).
Both ferric ions and cupric ions were added to 
mitochondria to determine whether the interaction of TBHP 
and free metals results in enhanced radical production in 
these organelles. Neither FeCl3 nor.CuCl2 added to 
mitochondria prior to TBHP significantly effected radical 
production (Table II) suggesting that interaction of non- 
liganded metals with TBHP is not an important reaction in 
this system. Taken as a whole, the chelator, sodium 
cyanide and metal (Fe and Cu) results suggest that TBHP 
interacts with a tightly bound metal center (e.g., heme 
iron) in the mitochondria.
We have investigated the effects of treating 
mitochondria with reagents that derivatize reduced 
sulfhydryl groups (53-55). The addition of N- 
ethylmaleimide (NEM) causes a 50% reduction in the 
intensity of the DMPO-methyl radical adduct signal (Table 
II), suggesting that sulfhydryl groups are involved in the 
mechanism of radical production. The addition of 5,5,- 
dithiobis(2-nitrobenzoic acid) (DTNB) provides conflicting 
results, as it has no significant effect on radical 
production (Table II). This lack of effect may be due to 
either the size or charge of this compound, both of which 
may prohibit it from reaching the site of NEM interaction. 
NEM may inhibit TBHP-induced radical production by reacting 
with reduced sulfhydryl groups in a heme protein resulting 
in a change in conformation such that the interaction 
between TBHP and heme iron is less efficient.
The role of oxygen in the reaction between TBHP and 
non-respiring mitochondria was examined by purging the 
mitochondria with either oxygen (aerobic incubation) or 
nitrogen (anaerobic incubation) prior to the addition of 
TBHP. Anaerobic incubation results in a 70% increase in 
the intensity of the methyl-DMPO adduct (Table II).
Aerobic incubation has no effect on radical production 
(Table II). The latter result indicates that normal 
atmospheric oxygen concentration is not limiting with 
respect to radical production by TBHP. Alternatively, the
145
increase in the formation of methyl-DMPO adduct under 
anaerobic conditions might be explained by the lack of 
competition by O2 with DMPO for methyl radicals- Thus, 
addition of methyl radicals to DMPO is more favorable under 
conditions of reduced oxygen concentration.
CHP has been shown to initiate lipid peroxidation in 
liver mitochondria; the initial step in this process is a 
reaction between the hydroperoxide and mitochondrial 
cytochrome P-450 (19). We have probed the effect of carbon 
monoxide, a potent inhibitor of cytochrome P-450, on TBHP- 
induced radical production in mitochondria to determine 
whether mitochondrial cytochrome P-450 is involved in the 
decomposition of TBHP. When mitochondria are purged with 
CO for 30 sec prior to the addition of TBHP, a 100% 
increase in the intensity of the methyl-DMPO adduct is 
observed (Table II). No increase is observed if the 
mitochondria are purged with air for 1 min following CO 
treatment. The fact that CO does not inhibit radical 
production suggests that mitochondrial cytochrome P-450 
probably is not involved in the mechanism by which TBHP 
induces radical production in mitochondria. Further 
evidence for this is provided by the fact that NEM has been 
shown to stimulate CHP/cytochrome P-450 initiated 
mitochondrial lipid peroxidation (19) whereas NEM inhibits 
TBHP-induced radical production in mitochondria (Table II).
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The effect of glutathione peroxidase, catalase and 
superoxide dismutase (SOD) on TBHP-induced radical 
production in mitochondria was studied to determine whether 
a role for hydrogen peroxide and superoxide exists in the 
mechanism of radical production. Triton X-solubilized 
mitochondria were used to enhance the accessibility of 
these enzymes to the site of interaction of TBHP. When 
glutathione peroxidase and GSH are added to mitochondria 
prior to TBHP, a 70% reduction in the intensity of the 
methyl-DMPO adduct is observed (Table II). This result may 
reflect involvement of hydrogen peroxide or it may be due 
to increased metabolism of the hydroperoxide since both 
H2O2 and TBHP are substrates for glutathione peroxidase 
(56). Addition of catalase results in a 40% inhibition of 
radical production (Table II). To determine if this 
reduction is due to destruction of H2O2 or is the result of 
a non-specific protein interaction, the mitochondria were 
treated with BSA prior to the addition of TBHP. The same 
40% inhibition of radical production is observed with BSA 
(Table II), indicating that the effect of catalase is due 
to a non-specific protein interaction. Thus, hydrogen 
peroxide does not appear to be involved in hydroperoxide- 
induced radical production. SOD has no significant effect 
on the intensity of the methyl-DMPO adduct signal, 
suggesting that superoxide is also not involved in the
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mechanism of radical production in the mitochondrial 
system.
Fate of Radicals in Mitochondria. We have examined 
the ability of TBHP to induce lipid peroxidation in rat 
liver mitochondria by the TBA test (28). The data in Fig.
8, Panel A shows that TBHP does induce the production of a 
low level of TBA-reactive materials (57), The inclusion of 
succinate results in a decrease in the level of TBA- 
reactive materials (Fig. 8, Panel A), suggesting that 
succinate inhibits lipid peroxidation. This result is 
consistent with the observation that succinate inhibits 
mitochondrial lipid peroxidation initiated by CHP (19).
This inhibition has been attributed to the ability of 
succinate to reduce hydroperoxides via the glutathione 
peroxidase pathway (58).
To determine the role of glutathione peroxidase in the 
inhibition of mitochondrial lipid peroxidation, we added a 
glutathione peroxidase inhibitor, mercaptosuccinic acid 
(MSA) (59), to the mitochondria prior to the addition of 
succinate and TBHP. Addition of MSA results in a level of 
TBA-reactive materials intermediate between that seen with 
TBHP in the presence and absence of succinate (Fig. 8,
Panel A), suggesting that MSA reduces the inhibitory 
ability of succinate. The fact that complete release of 
inhibition is not observed with MSA suggests that all of 
the inhibition by succinate is not due to reduction of
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Figure 8: Effect of respiratory substrate (Panel A) and a thiol pro­
oxidant (Panel B )  on malondialdehyde formation in mitochondria 
incubated with tert-butyl hydroperoxide (TBHP). Panel A - (A) 
Incubation containing 5.0 mg mitochondrial protein and 5 mM TBHP in
0.15 M NaCl at 25°C. 1.0 ml aliquots were removed from the
suspension and treated in the manner described under Methods. (B) 
Same as in A except 0.1 mM mercaptosuccinic acid added 3 min prior 
to TBHP and 15 mM sodium succinate added 1 min prior to TBHP. (G) 
Same as in A except 15 mM sodium succinate added 1 min prior to 
TBHP. (D) Same as in A except no TBHP added. Panel B - (A) 
Incubation containing 5.0 mg mitochondrial protein, 0.1 mM 
mercaptosuccinic acid and 5 mM TBHP in 0.15 M NaCl at 25°C. The
mercaptosuccinic acid was added 2 min prior to the addition of TBHP.
(B) Same as in A except no TBHP was added. (C) Same as in A except 
no mercaptosuccinic acid and TBHP were added. Each value is an 
average of three determinations + standard deviation.
hydroperoxides by the glutathione peroxidase pathway. The 
ESR data may provide a rationale for this difference. In 
the absence of respiratory substrate, TBHP induces the 
production of alkyl, alkoxyl and peroxyl radicals. In the 
presence of respiratory substrate (either BHB or 
succinate), a significant stimulation of alkyl radical 
production is observed (Fig. 6) while alkoxyl radical 
production is apparently unchanged and no peroxyl signal is 
present. ESR time-course studies (Fig. 9, Panel A) 
indicate that at the end of a 90 min period, the intensity 
of the alkoxyl-DMPO adduct is approximately the same in 
both respiring and non-respiring mitochondria while the 
intensity the methyl-DMPO adduct is significantly more 
intense in the respiring system. These results suggest 
that a greater degree of lipid peroxidation in non­
respiring mitochondria (Figure 8, Panel A) is due to 
generation of peroxyl radicals in this system. An enhanced 
production of alkyl radicals in respiring mitochondria is 
expected to result in some type of mitochondrial damage 
since these species are known to participate in both 
hydrogen abstraction and addition reactions (60-62).
Kensler and Taffe have suggested that methyl radicals 
produced in hydroperoxide-treated keratinocytes may 
modulate the cell phenotype during promotion or progression 
by alkylating cellular macromolecules (11). This is
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Figure 9: Change in Intensity of DMPO-Radical Adducts With Time in 
Mitochondria Treated With tert-Butyl Hydroperoxide in the Presence 
of DMPO. Panel A - Change in intensities of methyl-DMPO adduct 
(circles) and tert-butvlalkoxyl-DMPO adduct (triangles) in respiring 
(closed symbols) and non-respiring (open symbols) mitochondria 
treated with TBHP. Incubation containing 5.0 mg mitochondrial 
protein, 50 mM DMPO and 1.5 mM TBHP. Substrate (10 mM sodium 
succinate) was added 1 min prior to TBHP in the respiring 
mitochondrial system. Same instrument conditions as in Fig. 1 
except that single scans were recorded at 10 min intervals. Panel B 
- Change in intensity of methyl-DMPO adduct (circles), tert- 
butylalkoxyl-DMPO adduct (triangles) and tert-butvlperoxyl-DMPO 
adduct (squares) in non-respiring mitochondria treated with TBHP. 
Incubation containing 5.0 mg mitochondrial protein, 50 mM DMPO and
1.5 mM TBHP. Same instrument conditions as in Fig. 1 except that 
single scans were recorded at 2 min intervals.
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consistent with the hypothesis that methylation reactions 
are involved in eukaryotic gene expression (63).
Although thiols are known to protect against lipid 
peroxidation (64-66), these compounds can also act as pro- 
oxidants (67). Thiol-dependent lipid peroxidation is 
suggested to depend on direct reduction of iron by the 
thiol (68). GSH has been shown to act as a pro-oxidant in 
mitochondria; the addition of this compound to mitochondria 
results in lipid peroxidation and swelling (69). The 
glutathione peroxidase inhibitor MSA is a thiol; therefore, 
this compound may be expected to act as a pro-oxidant in 
mitochondria in a manner analogous to GSH. When MSA is 
added to non-respiring mitochondria, a significant amount 
of TBA-reactive materials are formed over a period of 2 
hours (Fig. 8, Panel B), indicating that this compound does 
induce lipid peroxidation in this organelle. A synergistic 
effect is observed when both MSA and TBHP are added to non­
respiring mitochondria (Fig. 8, Panel B); in this system, 
the level of TBA-reactive materials at 120 min. is 3 times 
that observed with MSA alone and 7 times that observed with 
TBHP alone. In non-respiring mitochondria, the level of 
NADH and FADH2 is low so the activity of the glutathione 
peroxidase pathway must also be low. In this condition, 
hydroperoxides will not be readily metabolized by this 
pathway. Thus, in a state of oxidative stress, thiols may 
no longer function in a protective manner but may act to
potentiate the effect of accumulated hydroperoxides, 
resulting in increased damage to the organelle as is 
observed in our in vitro system.
Mechanisms of Radical Production. Our ESR spin- 
trapping results indicate that TBHP interacts with a 
tightly-liganded metal center in non-respiring 
mitochondria; the site of interaction is identified as heme 
iron based on inhibition of radical production by sodium 
cyanide and lack of inhibition by metal chelators (Table 
II). In this regard, TBHP has been shown to react with a 
number of different heme proteins (32,35). In non­
respiring mitochondria, electron transport chain components 
are in their oxidized form. Thus, in all probability the 
initial reaction in this system is between TBHP and heme- 
bound ferric iron. Heme proteins are believed to catalyze 
the decomposition of hydroperoxides via Fenton reactions 
(70,71).
porphyrin-Fe111 + ROOH — —  > porphyrin-Fe11 + R00» + H+ (1)
porphyrin-Fe^ + ROOH — -> porphyrin-Fe^--*-^ + R0» + OH" (2)
An alternative mechanism has been proposed in which the 
initial event is homolytic cleavage of the oxygen-oxygen 
bond of the hydroperoxide molecule by the heme (72) ; this 
reaction results in the formation of an alkoxyl radical and 
heme-bound hydroxyl radical.
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porphyrin-Fe*-11 + ROOH ----> porphyrin-Fe-^-OH + RO» ( 3 )
porphyrin-Fe^-OH + ROOH ---> porphyrin-Fe-^-*- + ROO* + H2O (4)
The products of both of these mechanisms is an alkoxyl 
radical, a peroxyl radical and water. Several heme 
proteins are also believed to catalyze the decomposition of 
hydroperoxides via a peroxidase-type mechanism resulting in 
the formation of peroxyl radicals (73-76).
p o r p h y r i n - F e + ROOH — » porphyrin-Fe^-^O + ROH (5)
+  •
porphyrin-Fe^=0 + ROOH > porphyrin-Fe^=0 + R00» + H+ (6)
The addition of TBHP to non-respiring mitochondria in the 
presence of DMPO results in the formation of tert- 
butylperoxyl-DMPO, tert-butoxvl-DMPO. and methyl-DMPO 
adducts (Fig. 1). tert-Butylperoxyl radicals may be formed 
by either reaction 1, 4, 6 or a combination of these 
processes. Although tert-butoxyl radicals may result from 
either reaction 2 or 3, it is unlikely that reaction 2 
contributes significantly in a mitochondrial system if the 
heme protein involved is a component of the electron 
transport chain. If a cytochrome is reduced by reaction 1, 
the extra electron would be expected to be transferred to 
the next component of the chain and not to the 
hydroperoxide. If the process in reactions 3 and 4 occurs, 
there is no reduction of the iron, so an electron transfer 
to another component of the chain would not be a
154
possibility in this case. Thus, the most likely reaction 
for the formation of tert-butoxvl radicals in the 
mitochondrial system is reaction 3. tert-Butoxyl radicals 
may also arise via a reaction between tert-butvlperoxyl 
radicals since tertiary peroxyl radicals have been shown to 
undergo a self reaction (77).
2R00-------- 2R0* + 02 (7)
Once formed, a tert-butoxyl radical may participate in an 
addition reaction, hydrogen abstraction reaction or may 
undergo beta-scission to form a methyl radical and acetone 
(78,79).
CH3 0
I il
CH3-C-O • ----=► CH3-C-CH3 + *CH3 (8)
CH3
This is most likely the source of the methyl radicals that 
are observed in the form of the methyl-DMPO adduct.
Davies (32) has suggested that the peroxidase 
mechanism (reactions 5 and 6), which yields only peroxyl 
radicals, is the dominant process in a cytochrome c/TBHP 
system. Firstly, he observes DMPOX, which has been shown 
to arise via the reaction of high-valence-state (e.g., 
ferryl) species with DMPO (80). Secondly, the buildup of 
the alkoxyl-DMPO adduct appears to mirror the loss of the 
peroxyl-DMPO adduct. Thus, he proposes that alkoxyl-DMPO
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adducts are produced by breakdown of peroxyl-DMPO adducts.
We do not observe DMPOX in non-respiring mitochondria 
treated with TBHP in the presence of DMPO, although we 
cannot rule out the possibility that DMPOX is formed and 
then reduced via endogenous reducing agents (e.g., 
ascorbate, GSH) in the mitochondria. We also do not 
observe a correlation between the loss of peroxyl-DMPO 
adduct and formation of alkoxyl-DMPO adduct (Fig. 9, Panel 
B); therefore, both alkoxyl and peroxyl radicals appear to 
be formed directly in the non-respiring mitochondrial 
system. Although the peroxidase mechanism (reactions 5 and 
6) may function in this system, reactions 3 and 4 appear to 
be the dominant radical-producing process.
In a respiring mitochondrial system, our ESR spin- 
trapping results indicate that cytochrome c^ donates 
electrons to reduce TBHP resulting in radical production.
In the presence of DMPO, only tert-butoxyl-DMPO and methyl- 
DMPO adducts are observed. The absence of the tert- 
butylperoxyl-DMPO adduct suggests that TBHP only reacts 
with reduced heme iron in respiring mitochondria. Reaction 
2 is expected to be the initial radical-producing reaction 
in this system, resulting in the formation of tert-butoxyl 
radicals. These radicals then undergo beta-scission to 
form methyl radicals. The fact that no tert-butylperoxyl 
radicals are trapped suggests that reaction 1 is not a 
contributing reaction in the respiring mitochondrial
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system. This is logical since any heme iron oxidized via 
reaction 2 would be immediately reduced by electron 
transfer from the respiratory chain. Both the process 
shown in reactions 3 and 4 and that shown in reactions 5 
and 6 require an initial reaction of the hydroperoxide with 
ferric iron. Thus, the contribution of these pathways 
should not be significant in the respiring mitochondrial 
system.
When CHP is added to non-respiring mitochondria in the 
presence of DMPO, cumylperoxyl-DMPO, cumyloxyl-DMPO and 
methyl-DMPO adducts are observed (Fig. 3). The relative 
signal intensities of the three adducts is different than 
those observed with TBHP; the cumylperoxyl-DMPO adduct 
predominates while the cumyloxyl-DMPO adduct is almost non­
existent. This difference may suggest a change in 
mechanism of radical production. It may be that in the 
case of CHP, the peroxidase mechanism (reactions 5 and 6) 
is dominant. This also is reasonable since CHP is Known to 
interact with mitochondrial cytochrome P450 to yield 
peroxyl radicals (19).
Summary. TBHP induces the production of alkoxyl, 
methyl and peroxyl radicals in non-respiring rat liver 
mitochondria as shown by ESR spin-trapping results.
Studies with a number of additives suggest that TBHP 
interacts with a heme iron-containing protein to initiate 
radical production. A significant increase in methyl
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radical production is observed in respiring mitochondria; 
the magnitude of increase has been shown to be related to 
the respiratory control ratio of the mitochondrial 
preparation. Our studies indicate that cytochrome ci 
donates electrons to the hydroperoxide in this system. CHP 
and LHP have also been shown to induce radical production 
in liver mitochondria.
TBHP and CHP have been shown to induce radical 
production in keratinocytes via interaction with a 
cytosolic species (15), no radical production is observed 
with the mitochondrial fraction (15) . If the tumor- 
promoting ability of peroxides requires radical production, 
then peroxide-mitochondrial interactions may not be 
important in skin tumor promotion. However, in liver, 
peroxide-mitochondrial interactions may be important in 
peroxide-mediated tumor promotion since hydroperoxides 
induce radical production in this organelle.
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